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ABSTRACT
Oncogenesis, or the development of cancer, can arise when an imbalance exists between
1 v
cellular proliferation and differentiation, with a propensity for accelerated cell division. Critical 
enzymes are in place to ensure that cells progress through the cell cycle in a timely and regulated 
manner; the Polo-like kinases are one family of enzymes that exemplifies this regulatory function. 
Plk4 (Sak) is the most recently discovered mammalian Plk and has been shown to influence 
centrosome dynamics and to aid in mitotic progression. Using a candidate approach, this study 
identified putative interactions between Plk4 and proteins known to associate with other 
established mammalian Plks. Furthermore, in order to facilitate the characterization of Plk4 in 
future experiments, a cell line that stably expresses either wildtype or mutant Plk4 was created.
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CHAPTER I 
REVIEW OF LITERATURE
Polo-like kinases
The polo-like kinases (Plks) are a group of serine-threonine kinases that are highly 
conserved from yeast to humans (Glover et al, 1998). Plks are involved in a number of cell-cycle 
related events including bipolar spindle formation (Hamanaka et al., 1995; Glover et al., 1996), 
chromosome segregation, centrosome maturation in late G2/early prophase (Lane and Nigg, 
1996), activation of Cdc2, regulation of the anaphase-promoting complex, and execution of 
cytokinesis, thus emphasizing the importance of this group of kinases in mitotic progression 
(Lane and Nigg, 1996; Glover et al., 1998; Nigg, 1998). In addition, Plks have been implicated in 
playing major roles during the Gl/S transition as well as in DNA damage pathways (Barr et al., 
2004). Polo, the founding member of the Plk family, was originally identified in the fruit fly 
{Drosophila melanogaster). Mutations in the Drosophila Polo gene were found to produce 
embryos that exhibited abnormal mitotic networks of microtubules, and structural defects in 
centrosomal components (Glover et al, 1998). Plk family members have also been described in 
single cell organisms such as Cdc5 in Saccharomyces cerevisiae (Kitada et al, 1993), Plol in 
Schizosaccharomyces pombe (Okhura et al, 1995), CaCDC5 in Candida albicans (Bachewich et 
al., 2003), tbplk in Trypanosoma brucei (Graham et al., 1998), and most recently PLKA in 
Aspergillus nidulans (Bachewich et al, 2005), whereas in multicellular organisms such as 
Xenopus laevis and Caenorhabditis elegans, three or four homologues o f Plks have been 
described denoted Plxl/Plcl, Plx2/Plc2, and Plx3/Plc3, respectively, as well as the recently 
identified Plx4 (Kumagai and Dunphy, 1996; Ouyang et al., 1999; Chase et al., 2000; Duncan et 
al., 2001). In mammals, four Plk homologues have been identified to date: Plk 1 (Plk), Plk2 
(Snk), Plk3 (Fnk), and Plk4 (Sak), each of which are critical participants in various aspects of cell 
cycle progression. The increased number of Plks in higher organisms is likely directly related to
1
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an increase in the complexity of the cell cycle during the development of multicellular organisms 
and metazoans (Table 1).
Plks all share a high degree of structural homology in their N-terminal kinase domain, 
each containing a critical threonine residue in the activation segment that must be phosphorylated 
for proper activity (Cheng et al, 2003). Another characteristic feature of the Plks is the presence 
of one or two highly conserved, non-catalytic motifs in their C-terminal domains termed polo 
boxes (PB). Structurally, P lkl, 2, and 3 display high similarity in that there are two PB sequences 
designated PB1 and PB2, each comprising -80  amino acids (AA) (Lowery et al, 2005). These 
motifs are separated by a -20  AA linker region and are composed of a continuous six-stranded 
antiparallel p-sheet and an a-helix. Plk4, however, is structurally divergent from the other Plks in 
that it contains only one PB (Cheng et al, 2003; Leung et al, 2002). In terms of the Plk family, the 
remainder of this chapter will focus primarily on the Plks found in single celled organisms and 
Plks 1-3. Since my thesis is focused directly on Plk4, the background for this protein will be dealt 
with separately in Chapter 2.
Polo-box domain fPBD) structure and function
Collectively, the two PBs, the linker region between them, the 45 AAs N-terminal to 
PB1, and the amino acids C-terminal to PB2, all comprise a functional unit designated the PB 
domain (PBD) (Liu and Mailer, 2005). The PBD is a feature unique to the Plk members, as 
revealed by a BLAST search that showed the motifs within this domain do not occur in other 
proteins (Altschul et al, 1990). This is in contrast to other motifs such as the SH2, SH3, or MH2 
domains that are considerably more ubiquitous (Pawson and Nash, 2003). Analysis of the 
crystalline structure of Plkl revealed that its two PBs have identical secondary protein structure 
consisting of antiparallel P-sheets and an a-helix, as previously mentioned (Cheng et al, 2003).
2
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3Table 1. Selected Plks and their functions
Organism Plk m em ber Function
Drosophila melanogaster Polo Proper spindle formation
Saccharomyces cerevisiae Cdc5 Bipolar spindle and septal formation
Schizosaccharomyces
pombe Plo1
Assembly of mitotic spindle, 
prophase actin ring required 
for cytokinesis, and septation
Mammals Plkl
Mitotic related events e.g. 
centrosom e development, 
bipolar spindle assembly, 
mediating DNA dam age
Plk2
Immediate-early gene; also 
involved in embyonic 
developm ent, centriole 
duplication, and cell cycle 
progression
Plk3
Immediate-early gene; 
mediating DNA dam age 
response, tumor 
suppression; regulating 
mitosis
Plk4 Centriole duplication; M phase  progression
Xenopus laevis Plx1
Activation of Cdc25c for entry 
to mitosis; prom otes bipolar 
spindle formation at 
centrosom es; activation of 
APC/C; cytokinesis
Caenorhabditis elegans Plkl Nuclear envelope breakdown and completion of meiosis
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
4Structurally, the core of the PBD in Plkl, Plk2, and Plk3 show high resemblance, whereas the 
linker region found between the two PBs is quite dissimilar. As a whole, the PBD appears to be 
critical to the function and localization of the Plk members, as evidenced by mutation and 
deletion studies of this domain. In Plkl, for example, a conserved W414F mutation in the PB 
region of Plkl has been shown to disrupt the enzyme’s ability to migrate to spindle poles and 
cytokinetic filaments during mitosis (Cheng et al, 2003). The same mutation can also disrupt the 
ability of Plkl to complement the Cdc5 temperature-sensitive mutant in budding yeast (Lee et al, 
1998); these data suggest that W414 is one of the residues most critical to the function of the 
PBD. In addition, overexpression of the PBD in Plkl resulted in impaired spindle checkpoints 
and defective cytokinesis (Seong et al, 2002). Jiang et al (2006) reported that the PBD of Plk3 
was sufficient for proper subcellular localization, and that sequence changes to either PB motif 
disrupts proper migration to the centrosomes during interphase, spindle poles during mitosis, and 
midbody during cytokinesis. The PBD of Plk3 also proves to be crucial in regulating the G2/M 
checkpoint upon DNA damage such that its deletion completely eliminates the kinase’s,ability to 
induce a G2/M arrest (Jiang et al, 2006). Furthermore, ectopic expression of Plk3’s PBD in HeLa 
cells caused significant changes in cell morphology such as nuclear condensation and cell 
fragmentation, characteristics of cells undergoing apoptosis.
The PBD has also been suggested to regulate the kinase activity of certain Plk members, 
primarily through an intramolecular association with the N-terminal kinase domain leading to 
inhibition of catalytic activity. HeLa cells expressing C-terminal deletion mutants of Plkl 
exhibited increased kinase activity compared to the wildtype, suggesting that the loss of the PBD 
within this region led to a deregulation of the enzyme (Jang et al, 2001). In P lk l, C-terminal 
inhibition of kinase activity can be relieved through the phosphorylation of Thr210 in the N- 
terminal kinase domain, which impedes its interaction with the C-terminus, or through its 
mutation to an aspartate (Jang et al, 2002).
4
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
5The critical influence of the PBD in localization may be indicative of its ability to 
recognize specific protein binding partners at particular subcellular structures. Recent studies 
have proposed the PBD may indeed serve as a binding site for effectors Or substrate proteins (Elia 
et al, 2003). Lowery et al (2004) present evidence that characterizes the entire PBD as a binding 
module for phosphoserine/threonine molecules, and suggest that the PBDs of Plkl, Plk2, and 
Plk3 all recognize the same binding motif of Ser-[pSer/pThr]-[Pro/X]; this indicates that a 
‘priming’ phosphorylation of target proteins can enhance its recognition by these Plk members. It 
has been found that other mitotic regulators such as the cyclin-dependent kinases (Cdks) and 
MAP kinases can phosphorylate proteins that in turn bind to the PB domain, prompting 
localization of the Plk to its own substrate thus enhancing its kinase activity. Cdc25c, for 
example, is a confirmed substrate of Plkl that contains the optimal PBD binding site ST130P, 
while also consisting of a Cdk phosphorylation motif; indeed, Cdkl phosphorylates Cdc25c, 
which enhances its interaction with Plkl (Toyoshima-Morimoto et al, 2002) (see below). A study 
by Garcia-Alvarez et al (2007) revealed that the conserved W414 within the PBD originally 
attributed to proper Plkl localization is also critical to its substrate recognition. Mutation at this 
site eliminated P lk l’s ability to identify Cdc25c as its phosphorylation target, thus preventing 
Plkl from assisting in Cdc25c’s nuclear translocation (Garcia-Alvarez et al, 2007). Plk4 differs in 
that it contains only one conserved PB homologous to the PBs found in other Plk members, 
however, a second divergent ‘cryptic PB’ has been suggested to exist, a matter that will be more 
extensively discussed below (Leung et al, 2002).
Analysis of Plk loss-of-function and overexpression
The Plks have been characterized as a critical family of proteins that regulate a variety of 
cell cycle events. Loss-of-function, mutational and overexpression studies for the various Plk 
members have been crucial in dissecting their function within the cell and have highlighted the
5
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6significance of these proteins in controlling mitotic progression. In Drosophila, Polo mutants 
resulting from a recessive mutation in chromosome 3 were found to be embryonic lethal; larvae 
homozygous for this mutation failed to develop adult structures and eventually died in later stages 
of development (Sunkel and Glover, 1988). In addition, mutant embryos exhibited strikingly 
abnormal centrosome structures such as branched mitotic spindles and broad, unfocused poles; 
these defects in centrosomal organization would lead to unequal separation o f chromosomes and 
ultimately genomic instability (Sunkel and Glover, 1988). Clearly, Polo has a pivotal role in 
maintaining chromosomal integrity and thus proper development of the organism.
Cdc5 is found in the budding yeast Saccharomyces cerevisiae and is a critical gene 
involved in cell division (Lee and Erikson, 1997). Loss of function studies in CDC5 highlight the 
importance of its activity during mitosis whereby its depletion induced a late nuclear division 
arrest resulting in dumbbell-shaped cellular morphology (Kitada et al, 1993); this abnormal 
phenotype was attributed to nearly-separated nuclei from both parental cell and bud that was 
connected by a thin string of chromatin. Various temperature-sensitive mutants for cdcl5, cdc20, 
and dbf2, all of which affected mitotic progression and led to a defective growth phenotype in 
budding yeast, were able to be rescued by cdc5 (Kitada et al, 1993). Removal of the catalytic 
domain of this Plk member, however, completely abrogated this ability, suggesting that the kinase 
activity of cdc5 is crucial to its proper function. A separate study conducted on a temperature- 
sensitive mutant of cdc5 at its restrictive temperature resulted in a cell division arrest after spindle 
pole body (SPB) duplication, causing a failure of the cell to complete meiosis I (Dai et al, 2002). 
Overexpression of CDC5 resulted in the production of multinucleated cells as well as the 
presence of ectopic cytokinetic structures within abnormally-elongated buds (Kitada et al, 1993; 
Song et al, 2000). The mammalian Plk members Plkl and Plk3 are both able to rescue the cdc5 
temperature-sensitive mutant, thus underlining the conserved function o f these Plk members in 
mitosis (Ouyang et al, 1997; Lee and Erikson, 1997). Plk2 and Plk4, however, are not capable of
6
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7complementing the mutant phenotype in a similar manner, suggesting these two mammalian Plks 
likely diverged functionally at some point during the evolutionary process.
t .'H •
In the fission yeast Saccharomyces pombe, the Plk member Plot has several noteworthy 
functions, one of which is proper spindle assembly and function. Deletion o f the Plol gene leads 
to a characteristic phenotype defined by monopolar spindle formation in cells that are blocked in 
mitosis (Ohkura et al, 1995). Furthermore, cells lacking Plol are unable to form both a prophase 
actin ring, which is necessary for initiating the site for cytokinesis, and a septum, the cross-wall 
formed between mother and daughter cell during cell division (Ohkura et al, 1995). Conversely, it 
was found that overexpression of Plol can induce a state of multiple septation during any 
particular phase of the cell cycle (Ohkura et al, 1995). In Caenorhabditis elegans, RNA- 
mediated interference of the Plk homologue PLK-1 significantly disrupted proper embryonic 
development as a result of oocytes that were unable to divide (Chase et al, 2000). Close 
examination of the oocytes revealed an incomplete breakdown of the nuclear envelope prior to
. * , t-
ovulation, although they still remained amenable to fertilization as shown by the presence of 
sperm DNA within the embryo; however, the resulting embryos displayed an inability to progress 
through meiosis, exhibiting defects in chromosomal segregation as well as in expulsion of polar 
bodies (Chase et al, 2000). Ultimately, embryos never progressed beyond the single-cell stage 
and showed signs of multinucleation. In contrast to other Plk members, depletion of PLK-1 did 
not hinder the cell from undergoing centrosome duplication or nucleation o f microtubules (Chase 
et al, 2000). Indeed, in RNAi-treated embryos, the absence of PLK-1 still permitted formation of 
the mitotic spindle and replication of centrosomal structures as expected. These observations 
suggest that the loss of PLK-1 may not be capable of disrupting all aspects of the cell cycle and 
that certain events such as spindle assembly and centrosomal duplication can still prevail.
Plxl is a crucial participant in the cell cycle pathway of Xenopus laevis, having been 
shown to phosphorylate the Cdc25c phosphatase at its N-terminus resulting in its activation 
(Kumagai and Dunphy, 1996). Enhancement of Cdc25c’s activity then triggers a
7
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8dephosphorylation event on cyclin B/cdc2 or the mitosis promoting factor (MPF), thus pushing 
cells past the G2/M boundary into the mitotic phase; in turn, MPF induces activity o f  Plxl as part 
of an MPF positive feedback loop (Abrieu et al, 1998). Kumagai and Dunphy (1996) showed 
how treatment of cell extracts with anti-Plxl antibody significantly reduced Cdc25c activation, 
thus demonstrating that Plxl is critical for mitotic progression at the G2/M transition. A separate 
study that focused on the role of Plxl in the MPF amplification loop showed that 
immunodepletion of Plxl with antibodies against its C-terminus (thus eliminating its activation) 
resulted in suppression of MPF activity, arresting cells in the G2 phase and preventing entry into 
mitosis (Abrieu et al, 1998).
Ideally, to gain insight into the critical role the Plks play in mammalian embryonic 
development, a knockout organism would be generated that would enable observation and 
analysis of the resultant phenotype. Given that some of the Plks are essential proteins needed for 
regulating early stages of the cell cycle, however, it may not be feasible to create a null organism, 
since knockout of the alleles would likely be lethal to the developing embryo. Indeed, there are no 
established knockout organisms for Plkl or Plk3 due to their necessity in various critical events 
that enable proper mitotic progression. As a result, depletion of these Plks through antibodies or 
RNA-interference has been the primary method in studying their respective contributions to 
development and cell cycle. Plkl has been the subject of numerous studies and is therefore the 
most well-characterized mammalian Plk. Liu, Erikson, and colleagues (2003) transfected HeLa 
cells with double-stranded RNA targeting Plkl for depletion and discovered that cell proliferation 
was considerably retarded, and the viability of cells was compromised. Furthermore, cells 
deficient of Plk l showed signs of a block in G2/M, along with a propensity for apoptosis (Liu and 
Erikson, 2003). Cellular death was indicated by Caspase 3 induction (an apoptosis instigator), as 
well as fragmented nuclei and dumbbell-shaped chromatin due to unseparated sister chromatids. 
In a previous study, Lane and Nigg (1996) had originally observed a buildup o f cells that were 
unable to enter mitosis, and that contained fragmented and/or inappropriate numbers of nuclei
8
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9when Plkl was neutralized by micro7injected antibodies. In addition, cells lacking Plkl displayed 
abnormalities in mitotic spindle formation, as well centrosomes that failed to mature and separate 
(Van Vugt et al, 2004). Conversely, overexpression of Plkl in mammalian cells seems to 
instigate abnormal cellular proliferation and thus has become useful as a prognostic marker in 
tumor formation.
The depletion of Plk3 has also been subject to analysis to determine the function of this 
protein in vivo. One study used RNA interference to suppress Plk3 gene expression in human 
mammary epithelial cells and discovered that depleting Plk3 prevented cyclin E expression, a 
confirmed regulator of the G l/S transition, and therefore hindered cells from entering S phase 
(Zimmerman and Erikson, 2007). Furthermore, cells treated with anti-Plk3 lentivirus showed 
significant reductions in the proliferation marker Ki67, indicating these cells were no longer 
actively progressing through mitosis and had entered into a quiescent phase. Overexpression of 
Plk3 produces a contrasting phenotype to that of Plkl in that enforced levels of Plk3 lead to 
inhibited cellular proliferation as a result of apoptosis (Conn et al, 2000). Wang et al (2002) 
confirmed the pro-apoptotic role of Plk3 upon overexpression, revealing that ectopic Plk3 
expression can lead to a disruption of microtubule integrity and subsequently to changes in cell 
morphology such as shrunken cells and unseparated midbody structures; therefore, mitotic 
progression is halted and cellular death is observed (Wang et al, 2002).
The precise function of Plk2 in mammalian cells is relatively unknown. In adult mice, 
Plk2 expression has been detected in the brain. Ectopic expression of Plk2 can induce changes in 
cellular morphology and eventually induce apoptosis (Ma et al, 2003). While attempts to create 
knockout organisms for Plkl and Plk3 have been futile, experimenters have been able to create a 
null organism for Plk2, suggesting that depletion of this protein may not completely abrogate 
cellular proliferation and embryonic development. Ma and colleagues (2003) generated a Plk2 - / -  
mouse line through targeted disruption of the Plk2 gene locus and insertion of ES cells containing 
the perturbed gene into a mouse blastocyst. The result after breeding was a mouse line containing
9
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10
a mutation in both Plk2 alleles, which could then be assessed for defects in embryonic 
development, mitotic progression, and other aspects of its phenotype. Embryos derived from Plk2 
- / -  mice were analyzed and observed to develop at a slower rate with a subsequent delay'in 
skeletal growth compared to wildtype embryos (Ma et al, 2003). Histological evalutation of Plk2 
- / -  embryos also indicated reduced levels of phosphorylated histone H3, a protein utilized as an 
indicator of cellular proliferation (Ma et al, 2003). Furthermore, Plk2 - / -  embryonic fibroblasts 
exhibited a delayed G1->S progression, suggesting a possible role of Plk2 in promoting cells 
through the cell cycle.
Plks: regulation and cell cycle functions
Expression of the Plks is differentially regulated throughout the cell cycle (Lane and 
Nigg, 1996). Plkl expression, for example, peaks during late G2 and M phase and is involved in 
mitotic-related events such as centrosome development (Lane and Nigg, 1996) and bipolar 
spindle assembly (Ohkura et al, 1995). In addition, Plkl has been shown to phosphorylate cyclin 
B l, a component of mitotis-promoting factor (MPF) when complexed with Cdc2 kinase; the 
result is nuclear accumulation of MPF during prophase and subsequent initiation and coordination 
of M-phase events (Toyoshima-Morimoto et al, 2001). Cdc25c, a protein phosphatase also 
responsible for MPF activation, is phosphorylated by Plkl, being targeted to the nucleus upon 
modification (Toyoshima-Morimoto et al, 2002). In addition to promoting mitotic entry, Plkl 
displays an active role at the metaphase-anaphase transition, primarily by activating components 
of the anaphase-promotic complex (APC) (Nigg, 1998). The APC is an E3 ubiquitin-protein 
ligase responsible for degrading anaphase inhibitors; Plkl has been shown to phosphorylate APC 
components Cdcl6 and Cdc27 in vitro, suggestive of a direct role in APC regulation by Plkl 
(Glover et al, 1998). Plk2 [PCIJexpression occurs largely outside the mitotic stage during G1 
and its protein levels have a rapid turnover rate; data suggest it may aid in propelling cells
10
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11
through to S phase (Simmons et al, 1992; Liby et al., 2001; Ma et al., 2003). Unlike Plkl, Plk2 
does not contribute significantly to cell division per se, though it has been shown to be activated 
by a p53-mediated DNA-damage checkpoint in mitosis, suggesting a role in halting M-phase 
progression (Bums et al, 2003). Plk3 has been found to associate with mitotic components such 
as the bipolar spindles, spindle poles, and midbody (Glover et al, 1998). Levels of Plk3 were 
originally shown to remain relatively constant throughout the cell cycle, with maximal kinase 
activity occurring in late S and G2 phase (Ouyang et al, 1997). A recently published study, 
however, found that the level of Plk3 protein is in fact cell-cycle regulated, with maximal 
expression occurring during G1 phase (Zimmerman and Erikson, 2007). Data indicate that Plk3 
[PC2]augments cyclin E expression, a regulator of the Gl/S transition, through phosphorylation 
of Cdc25A and that cells depleted of Plk3 after overcoming the G l/S checkpoint can progress 
through the cell cycle unabated, but fail to re-initiate mitosis. Clearly, the Plks each play a unique 
role in controlling aspects of cell cycle progression.
Plks and centrosome regulation
The centrosome is an essential component of the microtubule organization centre 
(MTOC), a unique assembly of proteins that work together to ensure fidelity of cellular division. 
Comprised o f two centrioles surrounded by pericentriolar material, the centrosomes enable 
formation of the bipolar spindle, facilitating segregation of chromosomal material (Blagden and 
Glover, 2003). Numerous families of protein kinases have already been established as key 
regulators of the centrosomal cycle, including the cyclin-dependent kinases (Cdks), Aurora 
kinases, and the NIMA family of kinases (Okuda et al, 2000; Hannak et al, 2001; Fry et al,
2000). Additionally, the Plks have been shown to influence centrosomal dynamics. Nearly all of 
the Plk members have been shown to mediate centrosome duplication, though the precise 
mechanism by which this process occurs remains to be clearly defined. In Drosophila, expression
11
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of Polo allows for recruitment of essential centrosomal components and for its proper localization 
to the microtubule organization center (MTOC) (Dai et al, 2002). Without Polo, proper spindle 
assembly would be hindered leading to defects in chromosome segregation and cytokinesis. 
Further evidence for the role of Polo in centrosome regulation comes from its ability to 
phosphorylate Asp, a confirmed microtubule-linked protein that associates with centrosomes and 
assists in forming microtubule asters (Gonzales et al, 1998).
In yeast, spindle pole bodies (SPB) are considered to be the functional equivalent to the 
centrosomes found in mitotic-capable cells. The Plk Cdc5 in budding yeast has been linked to 
regulating SPBs, primarily through its functional interaction with verified SPB proteins such as 
dbf2, cdcl5, and M oblp (Luca et al, 2001; Menssen et al, 2001). It appears that Cdc5 enables 
translocation o f certain SPB proteins to its proper structures through phosphorylation of these 
substrates (Dai et al, 2002). Plol in the fission yeast localizes to the SPBs during early mitosis 
and continues its association until anaphase, where it assists in the formation of the mitotic 
spindle (Ohkura et al, 1995). Its association with the SPB is dependent on mitosis-promoting 
factor (MPF), while its dissociation relies on the anaphase-promoting complex (APC) (Mulvihill 
et al, 1999). In vertebrates, Plkl was first suggested to participate in controlling centrosome 
dynamics based on its localization to centrosomal structures when tagged with green fluorescent 
protein (GFP) (Golsteyn et al, 1995; Arnaud et al, 1998). Indeed, Plkl was found to associate 
with spindle components throughout mitosis, with an eventual redistribution throughout the cell 
following the transition from metaphase to anaphase (Golsteyn et al, 1995). Evidence points out 
that Plkl may be involved with promoting centrosome maturation, rather than mediating its 
duplication; depletion of Plkl was shown to cause monopolar spindles derived from centrosomes 
that were properly replicated, but that failed to grow to size and separate (Golsteyn et al, 1995). 
Lane and Nigg (1996) confirmed the role of Plkl in centrosomal maturation, showing that 
injection o f anti-Plkl antibodies into HeLa cells caused monoastral microtubule arrays stemming
12
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from underdeveloped centrosomes that contained reduced amounts of y-tubulin, a centrosomal 
protein marker.
Plk2 is another mammalian Plk that has been found to play a role in centriole duplication. 
Overexpression of Plk2 in CHO cells was shown to increase the number of centrosomes, while 
transfection o f a kinase-defective Plk2 inhibited centriole duplication in a dominant-negative 
fashion (Wamke et al, 2004). Additionally, silencing of endogenous Plk2 using small hairpin 
RNAs (sh-RNAs) interfered with replication of the centrioles in U20S cells, confirming the role 
of Plk2 in promoting centriolar duplication. Plk3 has also been linked to controlling centrosomal 
dynamics; it is found to localize to the MTOC during interphase, and continues its association 
even after centrosome duplication, eventually migrating to the spindle poles during mitosis and 
the midbody during cytokinesis (Dai et al, 2002). Wang et al (2002) confirmed that Plk3 
maintains association with the centrosomes or spindle poles throughout all phases of the cell 
cycle. They further showed that centrosomal localization by Plk3 is dependent on the 
microtubules, since depolymerization by exposure to low temperatures and nocodazole caused 
Plk3 to disperse throughout the cell. Although both Plkl and Plk3 associate with the centrosomes 
during interphase, the elevated abundance of Plk3 protein may indicate it has a more significant 
contribution in regulating centrosomes during this phase (Dai et al, 2002). Therefore, the Plk 
members may each possess a unique role in regulating centrosome dynamics throughout different 
stages of the cell cycle.
Plks and oncogenesis
Cancer can arise when specific genes involved in cellular proliferation become altered 
through mutation. For example, tumor-suppressor genes encode proteins that regulate abnormal 
propagation of cells by halting their progression through the cell cycle. When these genes become 
mutated and no longer functional, cell cycle progression may remain unchecked resulting in
13
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tumorigenesis. DNA damage checkpoints also exist within the cell cycle to ensure fidelity of 
DNA replication and correct propagation of genetic material. Genomic instability can ensue when 
heritable changes in genes accumulate as a result of base-pair mutations, chromosomal loss or 
rearrangement (Draviam et al, 2004). One type of genomic instability, called chromosomal 
instability (CIN), occurs when cells suffer from a high rate of chromosomal deletion or additions, 
which causes inappropriate amounts of genetic material to be distributed to dividing cells 
(Draviam et al, 2004). This is a significant contributor to conditions of aneuploidy and polyploidy 
with a potential for tumorigenesis. Draviam et al. (2004) highlight two potential causes of CIN, 
namely defects in spindle checkpoint proteins and changes in centrosomal regulation. The spindle 
checkpoint acts as a sensitive detector of misaligned chromosomes, which when prompted 
subsequently triggers pathways leading to mitotic arrest at anaphase; this ensures that the correct 
number of sister chromatids have attached themselves to the bipolar spindle for eventual 
distribution to daughter cells following cytokinesis. Because the Plks have been implicated in 
bipolar spindle as well as centrosome regulation, their deregulation has the potential to contribute 
to CIN and the development of malignancies, and indeed this seems to be the case. As previously 
described, depletion of Plkl results in monopolar spindles and underdeveloped centrosomes with 
a reduction in centrosomal protein recruitment, all characteristic features o f the CIN phenotype 
(Golsteyn et al, 1995; Lane and Nigg, 1996). Additionally, the failure of sister chromatids to 
separate has also been observed in HeLa cells subject to Plkl reduction by RNAi, which can also 
contribute to cases of CIN and tumorigenesis (Liu and Erikson, 2003). Excessive levels of Plkl 
have been observed in malignancies derived from numerous forms of cancer including gastric 
cancer, melanomas, breast cancer, ovarian cancer, endometrial cancer, gliomas, and thyroid 
cancer (for review see Takai et al, 2005). Plkl was also found to be overexpressed in human 
colorectal cancer, a class of malignancy for which 85% of the cases exhibit the CIN phenotype 
(Takahashi et al, 2003). Overexpression of Plkl has been utilized as a prognostic marker for 
tumor development, since mRNA and protein levels of Plkl have been correlated to accelerated
14
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cellular proliferation (Holtrich et al, 1994; Wolf et al, 2000). Even following an arrest in G2 
induced by DNA damage, overexpressed Plkl is still able to override the block and propel cells 
through mitosis (Smits et al, 2000). Thus, maintenance of normal Plkl levels proves crucial to 
preventing the abnormal proliferation of transformed cells.
Conversely, Plk3 has been negatively correlated to tumorigenesis and cellular 
proliferation, as evidenced by its downregulation in various cancers such as lung carcinomas (Li 
et al, 1996), rat colon tumors (Dai et al, 2002a), and head and neck squamous cell carcinomas 
(HNSCC) (Dai et al, 2000). Due to its activation upon DNA damage prompting immediate cell 
cycle arrest, Plk3 can be regarded as a tumor suppressor (Eckerdt et al, 2005); additional studies 
demonstrate how overexpression of Plk3 induces a halt in cell cycle progression leading 
eventually to apoptosis (Wang et al, 2002). In addition, Plk3 can phosphorylate the oncogene 
Cdc25c resulting in its downregulation, as well as phospho-activating the tumor suppressor p53,
both of which result in arresting the cell cycle (Ouyang et al, 1999; Xie et al, 2001). Thus, Plkl
. ' . *
and Plk3 can be viewed as exerting antagonistic effects on the progression of tumorigenesis.
Regulating centriole duplication during the cell cycle is also a mechanism of CIN 
prevention. Defects in centriole reduplication have been observed in the human osteosarcoma cell 
line U20S upon the introduction of small hairpin RNAs targeting Plk2, which resulted in 
suppression of its activity (Warnke et al, 2004). The overexpression of a dominant-negative 
mutant of Plk2 also inhibited centrosome duplication, thus confirming the role of Plk2 in 
regulating proper centrosome dynamics and therefore minimizing conditions of CIN (Warnke et 
al, 2004). Thus, it is evident that the Plks are essential regulators of centrosome dynamics and 
may provide insight into the molecular mechanisms driving tumorigenesis.
15
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Cell cycle kinases and the DNA damage response
A cell’s coping mechanism in dealing with DNA damaging agents is a critical process 
that ensures cell survival. Highly conserved pathways involving DNA repair mechanisms and 
cell-cycle checkpoints enable cells to maintain the integrity of its genetic information and ensure 
genomic stability. Without such devices, cancer can arise and threaten survival of the cell and, 
ultimately, the organism. Protein kinases are critical participants in the signal transduction 
pathways triggered in response to DNA damage. Through phosphorylation, these enzymes can 
regulate the activity of other proteins in an intricately coordinated network that enables the cell to 
respond appropriately to defects in genetic material. Key DNA damage proteins include 
phosphoinositide kinase homologs ataxia telangiectasia-mutated (ATM) and ATM- and Rad3- 
related (ATR), the protein kinases Chkl and Chk2, and the tumor suppressor protein p53 
(Elledge, 1996). ATM is primarily involved in repairing double-stranded DNA breaks resulting 
from ionizing radiation (IR), and regulates checkpoints at the Gl/S and G2/M transitions; ATR is 
responsible for monitoring problems in DNA replication forks during S phase due to UV 
exposure (Guo et al, 2000). Activation of ATR and ATM has been shown to phosphorylate other 
checkpoint kinases, namely Chkl and Chk2, which then regulate the G2/M transition through 
phosphorylation of a common target, Cdc25c. Chk2 is the mammalian homolog to Rad53 found 
in S. cerevesiae and upon DNA damage by IR is activated by ATM, however in cases of UV 
damage, activation is mediated by ATR (Matsuoka et al, 2000). Following damaged induced by 
UV, ATR can also phosphorylate Chkl and is involved in its regulation at the G2/M checkpoint.
Plks have been shown to participate in key DNA damage response pathways (Figure 1). 
In mammals, Plkl is inhibited following DNA damage prompting a subsequent arrest in the cell 
cycle during mitosis. Van Vugt et al (2001) showed that this damage-induced Plkl inhibition can 
occur in an ATM- and ATR- dependent manner, which is determined by the type of damage 
induced upon the cell. Since Plkl has been observed to bind and inhibit the tumor suppressor p53,
16
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Fig. 1. DNA dam age pathways and the elucidated roles of Plks. Genotoxic stress induced by 
ultraviolet (UV) exposure or ionization radiation (IR) triggers a signal transduction pathway that 
is initiated by ataxia telangiectasia-mutated (ATM) and ATM- and Rad3-related (ATR) proteins. 
ATM phosphorylates the downstream checkpoint kinase Chk2, resulting in its activation and 
subsequently causing it to suppress activity of Cdc25c, but enhance activity of p53; ultimately, 
both result in arresting the cell cycle at the G2/M transition, thus preventing damaged DNA from 
being propagated. ATR phosphorylates Chkl in a similar manner, which also results in Cdc25c 
being inhibited. Plkl and Plk3 have both been implicated as intermediary participants in the DNA 
damage response. Plks have opposing effects on Cdc25c activity with Plkl inhibiting Cdc25c 
upon phosphorylation, while Plk3 induces its activation upon phosphorylation. Plkl and Plk3 
share similar roles in phosphorylating Chk2, albeit on different residues, with both contributing 
to activation of this checkpoint kinase thus leading to mitotic arrest. The role of Plk4 in the DNA 
damage pathway has not been clearly identified; to date, no putative interacting partners for Plk4 
have been described. By analyzing whether or not Plk4 has a functional association with 
established participants of the DNA damage response, a more accurate characterization of this 
relatively elusive protein may be achieved. Black arrows denote activation; red bars denote 
inhibition.
17
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it is deemed to have a counteracting effect on DNA-damaged induced cell cycle arrest (Dai and 
Cogswell, 2003). Plk3 is also a key participant in the response pathways to DNA repair,
I .j, .
becoming rapidly activated by ATM when cells are exposed to IR and oxidative stress (Xieef al,
2001). In contrast to Plkl, Plk3 has an activating effect when it phosphorylates p53 upon DNA 
damage, which contributes to the tumor-suppressing response (Xie et al, 2001). In addition to the 
phosphoinositide kinases ATM and ATR, Chk2 is another component of the DNA response 
pathway that has been shown to associate with certain Plk members. Studies have demonstrated 
that overexpression of Plkl enhances phosphorylation of Chk2 at T68, a site that is involved in 
Chk2 localization to centrosomes and midbody, as well as in Chk2 activation, which ultimately 
induces a halt in mitotic progression; in this respect, Plkl has a positive effect on cell cycle arrest 
(Tsetkov et al, 2003). Although Plk3 targets a different residue on Chk2 for phosphorylation, its 
effects on the activation of this kinase are similar to that observed by P lk l, though in vivo its 
interaction requires ATM as a mediator (Bahassi et al, 2002). Despite the elucidated roles of 
certain Plk members in the DNA damage response pathways, the role of Plk4 has yet to be clearly 
defined.
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CHAPTER II 
PLK4/SAK
Protein Structure
Plk4 is found on chromosome 3 in mice, and chromosome 4q27-28 in humans, a location 
that is susceptible to chromosomal deletions and reorganizations characteristic o f human cancers 
(Swallow et al, 2005). Within the kinase domain is a critical Lys41 residue that, when mutated, 
results in complete inactivation of the enzyme (Figure 2). The T-loop at the C-terminus in turn 
consists of a required Thrl70 residue that results in increased kinase activity as a result of 
mutation. Plk4 is structurally distinct from its family members in that it contains only one PB 
domain. Despite this structural distinction, a ‘cryptic’ PB domain has been suggested that 
encompasses amino acid residues 596-836 within the C-terminal domain; it is believed to enable 
self-association of the enzyme, namely through interaction with the enzyme’s kinase domain 
(Leung et al, 2002). Plk4’s single PB region is comprised of a cluster of hydrophobic residues 
that are conserved amongst several Plk family members; it also contains two conserved charged 
residues—Asp868 and Lys906—that interact to form a salt bridge, facilitating the dimerization of 
the PB domain both in vitro and in vivo (Leung et al, 2002). This novel dimer then localizes to 
various cellular structures including the nucleolus during G2, centrosomes during early G2/M 
phase, and to the cleavage furrow during cytokinesis (Leung et al, 2002; Hudson et al, 2001). 
Localization studies o f the isolated PB domain of Plk4 have shown that the protein can still 
migrate to the centrosomes during mitosis. Expression of a truncated Plk4, which lacks the PB 
domain, still exhibits proper localization; however, a more extensive C-terminal deletion o f the 
region downstream of the kinase domain up to and including the PB resulted in mislocalization of 
the enzyme (Leung et al, 2002). In this respect, Plk4 may be distinct to other Plk members in that 
the PB is necessary, but not sufficient, for proper localization and that regions outside the PB may 
assist in this process.
20
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Fig. 2. Plk4 protein structure. Plk4 contains an N-terminal kinase domain, a single C-terminal 
polo-box domain (pb), as well as three PEST sequences associated with protein stability. A 
cryptic pb is also located within the C-terminus. Within the kinase domain are two conserved 
residues, Lys 41 and Thr 170, that when mutated render the kinase catalytically-inactive and 
constitutively-active, respectively. Numbers indicate the amino acids comprising the designated 
regions.
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Regulation of Plk4 and its role in mitosis
Regulation of Plk4 expression occurs at both the pre- and post-transcriptional levels. Two 
isoforms of murine Plk4 exist, Plk4-a and Plk4-b, which differ in their stability at the post- 
transcriptional level. Structurally, these two isoforms of Plk4 are distinct in that Plk4-a comprises 
three PEST sequences that correlate to its susceptibility to degradation. One PEST cluster resides 
in the N-terminus, while the other two are in close proximity at the C-terminus. The Plk4-b 
isoform is significantly less abundant than its Plk4-a counterpart (Fode et al, 1996). Plk4-a 
exhibits a very short half-life of approximately 2-3 hours, being subject to multiubiquitination 
that targets the protein for eventual proteolysis. Removal of these sequences in human Plk4 can 
relieve PEST-related protein degradation and can improve the stability o f the protein when 
overexpressed (Yamashita et al, 2001). In addition, Tec protein tyrosine kinase effectively 
thwarts PEST-dependent proteolysis upon phosphorylation of Plk4, while also increasing Plk4’s 
kinase activity (Yamashita et al, 2001).
At the transcriptional, mRNA level, Plk4 expression varies throughout the cell cycle, 
with a gradual increase occurring from S through M phase (Fode et al, 1996). Following 
ubiquitination, Plk4 is degraded by the anaphase promoting complex (APC) and returned to 
resting phase levels (Swallow et al, 2005). Peak levels of Plk4 during M phase suggest its 
presence is necessary for completion of mitosis (Hudson et al, 2001). A murine Plk4 null mutant 
was generated through targeted mutation of the Plk4 gene locus to study the phenotypic effects of 
Plk4 loss-of-function. Cells derived from Plk4 - / -  mice in fact showed signs o f mitotic failure, as 
well as elevated levels of cyclin B1 and phosphorylated histone H3, proteins indicative of an 
arrest in anaphase (Hudson et al, 2001). Furthermore, rounded, dumbbell-shaped cells were 
observed in Plk4—/— blastocyst cultures, which suggests a telophase arrest (Hudson et al, 2001). A 
block in the cell cycle due to the absence of Plk4 would subsequently trigger pathways leading to 
apoptosis, as is in fact seen in null embryos displaying a high rate of cellular death. As a result,
22
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observed in Plk4—/— blastocyst cultures, which suggests a telophase arrest (Hudson et al, 2001). A
block in the cell cycle due to the absence of Plk4 would subsequently trigger pathways leading to
*
apoptosis, as is in fact seen in null embryos displaying a high rate of cellular death. As a result, 
Plk4 null embryos were found to arrest 7.5 days into embryonic development (Hudson et al, 
2001). Evidently, Plk4 is necessary for the cyclic destruction of cyclin B1 and therefore crucial 
for allowing cells to properly exit from mitosis.
Plk4 in tumorigenesis
The significance of Plk4 in cancer and tumorigenesis has also been observed in 
experiments with mice which contain only one functional Plk4 allele (Plk4 +/-). Greater than 
50% of 22-24 month old heterozygous Plk4 mice develop tumours primarily in the liver and lung 
tumors compared to less than 3% of their wildtype littermates (Ko et al, 2005). In addition, cells 
obtained from the maligpant tissue in Plk4 + /- mice displayed high mitotic irregularities such as 
multiple centrosomes and multipolar spindles. Examination of [PC3]Plk4 + /-  mouse embryonic 
fibroblasts (MEFs) exhibited increased incidences of mis-segregated chromosomes and aberrant 
centrosome number (Ko et al, 2005). These cell cycle defects would likely contribute to cases of 
aneuploidy or polyploidy and thus enhance development of chromosomal instability and 
contribute to tumorigenesis. Indeed, it was found that defects in mitotic lesions excised from Plk4 
+ /- mice livers exhibited primary hepatocellular carcinomas, while papillary adenocarcincomas 
were observed peripherally in lung tissue. Multifocal tumors were prevalent in the malignant liver 
tissue of heterozygous Plk4 mice, displaying high disorganization of cells that were arrested in 
mitosis (Ko et al, 2005). Liver cells from Plk4 + /-  mice livers that were subjected to partial 
hepatectomy displayed multipolar spindle structures, a disordered array of hepatocytes, as well as 
a high incidence of aberrant mitotic figures; this indicated a gross deficiency in cells progressing 
through mitosis (Ko et al, 2005). Additionally, cancerous lung tissue showed signs of atypical
23
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cells when compared to normal tissue derived from wildtype mice. These observations point to a 
haploinsufficient condition for Plk4, in which one functional allele is not adequate to produce the 
normal phenotype. Undoubtedly, Plk4 is a critical factor in cell cycle progression such that its 
absence can lead to mitotic abnormalities and subsequently contribute to oncogenesis.
Plk4 in centriole duplication
Recent evidence highlights the role of Plk4 in regulating centriole duplication during S 
phase of the cell cycle. Endogenous Plk4 has been found to associate with centrioles, as 
evidenced by its colocalization with structure-specific proteins such as centrin and y-tubulin 
(Hudson et al 2001; Leung et al 2002; Habedanck et al, 2005). Abrogation of Plk4 function has 
been shown to cause a gradual decrease in centriole numbers following successive rounds of 
mitosis, and/or the appearance of abnormal mitotic spindle morphology (Habedanck et al, 2005). 
This resulted in many cells left with acentriolar poles or monopolar spindles, both conditions that 
inhibit proper segregation of sister chromatids and contribute to aneuploidy and CIN. 
Bettancourt-Dias and colleagues (2005) further supplemented these findings with evidence of 
reduced centriolar numbers in HeLa and U20S cells following the silencing of Plk4 using 
siRNA, which may be the result of defective centrosome duplication, separation, or segregation. 
Again, the abnormal spindle organization that would result from the loss of centrioles 
demonstrates the importance Plk4 may have in preserving mitotic fidelity in cells.
Candidate Approach to elucidating Plk4 interacting partners
Plks play a significant role in regulating crucial aspects of the cell cycle as well as in 
mediating DNA-damage responses. As part of an expansive network of proteins that participate in 
these regulatory events, it is no surprise that Plks have functional interactions with a variety of 
other kinases, which can affect the protein’s activity, stability, localization, or other protein 
associations. Various studies have already confirmed that different Plk members can target
24
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common substrates in pathways triggered by DNA-damage as well as common components of 
cell cycle regulation (Table 2). Some candidate substrates of Plks have been described in studies, 
including Cdc25c (Plxl, Plkl, Plk3) (Abrieu et al, 1998; Toyoshima-Morimoto et al, 2002; 
Ouyang et al, 1997), p53 (Plkl, Plk3) (Ando et al, 2004; Xie et al, 2001), and P-tubulin (Polo)
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Table 2. Plks and candidate substrates
Candidate
Substrate Plk M ember Proposed Function
Cdc25c Plxl Activation of Cdc25c
Plkl Nuclear translocation of Cdc25c to allow activation of MPF
Plk3 Nuclear translocation o f Cdc25c to allow activation of MPF
p53 Plkl Inhibits transactivation activity and pro-apoptotic function of p53
Plk3 Promotes apoptotic function o f p53 in response to DNA damage
Chk2 Plkl Cell cycle arrest via Cdc25c inhibition
Plk3 66
a-tubulin Plkl Mediating spindle assembly
P-tubulin Polo ?
Plkl Mediating spindle assembly
y-tubulin Plkl Mediating spindle assembly
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(Tavares et al, 1996). In addition, Chk2, has been shown to be phosphorylated by both Plkl and 
Plk3 upon DNA damage, albeit on different residues, which as a result triggers a cell cycle block 
through inhibition of Cdc25c (Tsetkov et al, 2003; Bahassi et al, 2002). In addition, ATM is 
involved in mediating inhibition of Plkl upon IR damage, as well as in activating Plk3 to induce 
DNA repair and an arrest in the cell cycle (Van Vugt et al, 2001; Xie et al, 2001). Little is known 
about whether or not Plk4 also participates in these major pathways that control the cell cycle or 
the response to DNA damage. The major focus of my research was to determine whether or not 
Plk4 also targets some of these common substrates. This provides a basis for elucidating novel 
substrates of Plk4 and allows for a more defined characterization of this relatively unknown 
kinase.
Plk4-Expressing Stable Cell Lines
Obtaining significant expression levels of Plk4 in transient systems has been a significant 
and ongoing problem faced in early phases of this study. This presented set-backs when 
attempting to perform experiments requiring overexpression of Plk4 protein such as in co- 
immunoprecipitation studies that typically require ample levels of protein in order to detect 
transient protein:protein interactions in vivo. In addition studies with Plk4 have been problematic 
in that there are no suitable antibodies available for these co-immunoprecipation-based screens 
for interacting partners.
The ability to express high levels of a gene of interest is an important tool in molecular 
biology. To accomplish this, the foreign DNA must somehow be introduced into the cell in order 
to be transcribed by the host’s expression machinery. Most applications of transfection require 
only that the gene be transiently expressed, however, inconsistent gene expression and low 
protein yield are common disadvantages associated with such transient methods. The 
establishment of a stably-transfected cell line greatly enhances the level of gene expression in
27
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cases where high levels of purified protein are required. Therefore, another objective of this study 
was to establish and optimize a stable expression system for Plk4 constructs that would help to 
circumvent the problems experienced with minimal and inconsistent gene expression.
Generally, to establish a stable cell line, the gene of interest must be cloned into a vector 
containing a gene conferring resistance to a certain agent. The expression vector is then 
transfected into the desired cell line and permitted to undergo overexpression. Subsequently, 
those cells that successfully incorporated the foreign DNA into its genome can then be selected 
for upon addition of the selective agent, resulting in a population of cells stably expressing the 
desired gene. Additionally, the stable expression system can be made inducible through the 
incorporation of a repressor protein that will inhibit transcription of the foreign gene; this allows 
for tighter controls over the expression system, particularly when toxic proteins are generated.
One means of regulation typically employed in mammalian expression systems is based 
on the bacterial tetracycline operon (Figure 3). Cultured cells containing the plasmid encoding the 
tetracycline repressor (tetR) are grown in the absence of tetracycline. Binding of, the tetR 
homodimers to the inducible expression plasmid prevents expression of the gene of interest. Only 
upon addition of tetracycline to the medium will a conformational change in the repressor protein 
result, permitting induction of gene expression.
A problem often encountered with the establishment of stable cell lines is that 
overexpression of the protein of interest creates an unfavourable condition for the cell. Studies 
that required imposed expression of Plks in mammalian cells presented evidence that such a 
condition can be detrimental to a cell’s survival. For example, enforced expression of Plk3 in 
mammalian cells results in suppressed proliferation and inhibits colony formation, which upon 
further analysis is attributed to chromatin condensation and apoptosis (Conn et al, 2000). Thus, 
constitutive overexpression of Plk3 would be lethal to the cell and hinder the possibility for 
further experimentation. Overexpression of Plk4 has been shown to induce the formation of 
multiple centrosomes, a condition that would eventually give rise to aberrant chromosomal
28
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segregation and contribute to chromosomal instability (Habedanck et al, 2005). It is likely that the 
continued production of Plk4 protein, as would be seen in a stable expression system, would have 
disruptive effects and greatly compromise the cell’s survival. Therefore, a supplementary focus of 
the present study was to establish stable cell lines that are inducible rather than constitutive for 
Plk4 expression. This provides an invaluable tool in our ongoing studies.
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Fig. 3. Mechanism of repression of the inducible expression vector utilized for stable cell 
line creation. Brief descriptions of the repressive mechanism are included in the diagram. 
P Cmv indicates the cytomegaloviral promoter that regulates transcription o f  the repressor 
gene. TetR represents the tetracycline repressor proteins that bind to the tandem tetracycline 
operator sites (TetCh) situated upstresam of the gene of interest in the inducible expression
. 1 . t
vector. Red triangles represent the tetracycline (Tet) molecules that can bind tetR and induce 
its conformational change. Ultimately, the effect of tetR modification is to derepress 
expression of the gene of interest.
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CHAPTER III 
AIMS OF THIS STUDY 
To date, no known interacting partners have been identified for Plk4; therefore, to clearly 
define its function in the cell cycle and in DNA damage pathways still remains an elusive task. 
This study aimed to investigate putative interacting partners for Plk4 in the hopes elucidating a 
more precise role of the protein in responding to genotoxic stress and in regulating mitosis. On the 
basis of the candidate approach, experiments were performed to determine if, in addition to Plkl 
and Plk3, Plk4 can also interact with some of the same interacting partners. In addition, a human 
embryonic kidney cell line was established that stably expresses Flag-Plk4 and Flag-K41M.
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CHAPTER IV 
MATERIALS AND METHODS 
Preparation of competent Escherichia coli (E. coli) cells
Glycerol stocks of Top 10 F’ Pilus E.Coli cells were used to inoculate 10 mL of TYM 
media in a 50 mL Erlenmayer flask and allowed to grow in a shaking incubator for 16 hours at 
37°C. After incubation, 1 mL of the culture was subsequently added to 100 mL of TYM media 
that was prewarmed in a 500 mL flask. Cultures were again grown at 37°C and ODs6oo were 
intermittently taken until a value of 0.5 was attained. After cooling the flasks through gentle 
agitation on ice, the cultures were transferred to sterile Oakridge tubes and centrifuged at 4°C for 
10 minutes at 4000 x g. Subsequently, the supernatant was decanted gently to prevent any 
disturbance to the pellet. 4 mL of ice-cold TFBII buffer (30 mM potassium acetate, 100 mM 
rubidium chloride, 10 mM CaCl, 50 mM MnC12, 15% glycerol) was added to each tube and used 
to resuspend the pelleted cells through repeated pipetting, all completed while tubes were on ice 
to ensure a cold environment for the cells. After resuspension, 100 uL of the cells were quickly 
but carefully aliquoted into sterile microcentrifuge tubes and subjected to flash-freezing in liquid 
nitrogen. The prepared cells were then stored at-80°C.
Standard Bacterial Transformation
100 uL of Top 10 F’ Pilus E.Coli cells were transformed with 1 ug o f  DNA and allowed 
to sit on ice for 30 minutes. After incubation, the cells were then heat shocked at 37°C for 30 
seconds. 500 uL of LB was added to transformed cells, which was then incubated at 37°C for 45 
minutes. The sample was spun at 750 x g in a table-top microcentrifuge for 5 min, and pelleted 
cells were resuspended in 100 uL of LB broth. After plating the cells onto LB-Amp plates using 
sterile technique, the culture dishes were then incubated at 37°C overnight to permit the growth 
of transformed colonies.
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Boiling mini preps ,
For a boiling mini prep protocol, a standard bacterial transformation method was first 
performed using the desired DNA vector. Any colonies that were observed after 18 hrs at 37°C 
were picked and grown in 2 mL of LB broth containing 100 ug/mL ampicillin overnight. Each 2 
mL growth culture was centrifuged at 4000 x g for 5 min to pellet the cells and the supernatant 
was then carefully decanted. 100 uL of boiling mini prep solution (8% glucose, 5% Triton X-100, 
50 mM EDTA, 50 mM TRIS pH 8.0, 10 mg/mL lysozyme) was used to resuspend the pelleted 
cells, which were then boiled for 30 sec in a hot water bath. Lysed cells were placed on ice for 30 
minutes, and then spun in a cold microcentrifuge for 15 min at 4000 x g. The supernatant, which 
contained the plasmid DNA, was then transferred to a fresh Eppendorf tube.
Standard Transfection protocol and SDS-PAGE
Human embryonic kidney (HEK-293) cells were maintained in Dulbecco’s Modified 
Eagle’s Media (DMEM) {Sigma) containing 10% fetal bovine serum, 2 mM L-glutamine, 1%. 
Pen-Strep {Sigma), 250 ug/mL Gentamacin {Sigma), 250 ug/mL Fungizone {Sigma), and stored 
in a 37°C and 5% CO2 humidified incubator. The day before transfection, cells were trypsinzed 
and counted on a hemocytometer, then seeded onto 10 cm tissue culture dishes at a density of 1 x 
106 cells per plate. The next day, fresh, complete medium was replenished onto plates and 6 ug of 
Flag-Plk4 and its various constructs were transfected using Effectene™ {Qiagen) according to the 
manufacturer’s protocol; non-transfected cells were included as a negative control. After 18 hrs, 
cells were lysed with 1 mL lysis buffer (50 mM Tris-Cl, 100 mM NaCl, 500 mM EDTA, 1% 
Triton-X) on ice for 20 min. Lysates were spun in a microcentrifuge at 4000 x g for 20 min at 4°C 
to remove any cellular debris. IX loading buffer containing 5% (3-mercaptohethanol was added to
35
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20 uL of the lysates, and the samples were boiled for 5 min; 20 uL o f the sample was loaded onto 
an 8% protein gel and subjected to SDS-PAGE for 90 min at 115 V.
Western blot analysis
After SDS-P AGE, the proteins were then transferred onto PVDF membrane using a semi­
dry method at 12 V for 45 min, and the membranes were then blocked with Tris-buffered Saline 
and Tween (TBST) buffer for 1 hr at room temperature with gentle agitation. Blots were 
incubated with Anti-FLAG M2 monoclonal antibody (mouse) in TBST buffer (1:10,000) for 1 hr 
at room temperature, washed three times for 5 min each with TBST, and probed with anti-mouse 
horseradish peroxidase as a secondary antibody (1:60,000) for 45 min. Membranes were again 
washed 3 times and incubated with 1 mL SuperSignal West Femto Maximum Sensitivity 
Substrate (Pierce) dilution for 5 min to allow for reaction between the anti-mouse horseradish 
peroxidase and its substrate. Proteins were then visualized by chemiluminesence.
Stripping of Western Blots for re-probing
When a blot was required to be re-probed with a different primary antibody, a stripping 
protocol was used to remove any bound primary and secondary antibodies from the initial 
Western Blot. After washing the blot three times with TBST for five minutes each, 20 mL of 
stripping buffer (lOOmM p-mercaptoethanol, 2% SDS, 62.5mM Tris HC1 at a pH of 6.8) pre­
warmed to 50 °C was added to the blot, which was then incubated with gentle agitation for 30 
min at 50 °C. The stripping buffer was then discarded, and the blot was washed 3 times with 
warm TBST (50 °C) in 10 minute intervals. Blots were then ready to be probed with the 
appropriate antibody.
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Creation of Stable Cell Lines 
Site-directed mutagenesis
As an initial step in the creation of a tetracycline-inducible stable cell line, the Stratagene 
QuikChange site-directed mutagenesis protocol was used to introduce an A flll site into constructs 
encoding either a wildtype Flag-Plk4 or a kinase-dead FLAG-K41M protein. PrimerX, a web- 
based primer-design program (Lapid, 2002), was utilized to design the introduction of the A flll 
site (CTTAAG) upstream of the open reading frame that encoded the FLAG-tagged protein. The 
site was introduced in a manner that would allow the entire coding sequence, including the FLAG 
epitope, to be shuttled into the inducible expression vector PCDNA4/TO (Invitrogen). The 
forward and reverese primers designed are listed as follows respectively: 5’-
GAGGT CT ATAT AAGC AGAGCTCGCTT AAGG AACCGTC AGAATT AACC ATGG AC-3 ’ 
(designated ‘ForPFU’) and 5’-GTCCATGGTTAATTCTGACGGTT
CCTTAAGCGAGCTCTGCTTATATAGACCTC-3’ (designated ‘RevPFU’). Briefly, the 
mutagenesis reaction was setup as follows: each reaction contained 50 ng of Plk4 template DNA, 
125 ng of forward and reverse primer, 1 X PFU polymerase buffer (Stratagene•), lOOmM dNTP 
(dATP, dGTP, dTTP, dCTP), and 2.5 U of cloned Pfu DNA polymerase in a total volume of 50 
uL. PCR cycling conditions were performed as follows: segment 1, 1 cycle at 95°C for 30 sec, 
and segment 2, 12 cycles of the following: 95 °C for 30 sec, 55°C for 1 min, and 68 °C for 13 
min. After the PCR reaction was complete, 10 U of Dpnl restriction enzyme (NEB) was added to 
the amplified samples in order to digest any methylated, nonmutated parental DNA. Samples 
were pipetted up and down gently, spun at 4000 x g for 1 min, and then placed at 37°C for 1 hour.
Various aliquots of the Dpnl (NEB) digested PCR product (5 uL, 10 uL, and 20 uL) were 
individually transformed into Top 10 F’ Pilus E. Coli competent cells, which were prepared 
according to standard transformation protocol. After an overnight incubation individual 
transformed colonies were carefully picked with a sterile pipette tip and singly dispensed into a 2 
mL culture of LB-Amp containing 100 mg/mL of ampicillin in a round bottom polypropylene
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tube. Cultures were placed in a shaking incubator at 37 °C for 18 hrs and plasmid DNA was 
isolated from grown samples using the standard boiling mini prep protocol, as described 
previously. To analyze the DNA for successful mutagenesis, A flll (NEB) and EcoRI (NEB) 
restriction enzymes were used to digest 1 ug of each DNA sample for 2 hours at 37°C. The 
reaction mixtures were then analyzed on a 1% agarose gel to confirm that the A flll restriction site 
had been properly introduced. Any positive clones were then propagated by transforming 5 ug of 
the remaining boiling miniprep sample as per standard procedure. Plasmid DNA was then 
isolated using the QiaPrep Spin MiniPrep Kit from Qiagen according to the manufacturer’s 
instructions.
Cloning o f Flag-Plk4 constructs into PCDNA4/TO vector
To extricate the gene of interest into the inducible expression vector, 5 ug Flag-tagged 
Plk4 construct (with A flll site introduced) and PCDNA4/TO vector (Invitrogen) were each 
digested with 1 U each of A flll + Smal, and A flll + EcoRV (NEB), respectively, at 37°C.for 2 hrs 
according to standard methods. Samples were placed on the heating block at 80°C for 20 min to 
heat inactivate all restriction enzymes used in the reaction. 400 ng from each digest reaction were 
subsequently loaded onto a 1% agarose gel and separated through electrophoresis to confirm 
complete digestion. The remaining digested sample was used to perform two sets of ligation 
reactions: 150 ng of Flag-Plk4(4/?/7) [or Flag-Plk4-K41M(4/7Z/)] digest mixture was combined 
with 50 ng of the PCDNA4/TO digest to make a 3:1 ratio of insert:vector. Similarly, a 1:1 ratio of 
insert:vector was also tested using 50 ng of each DNA component. The reaction also contained 
IX T4 DNA Ligase buffer and 1 U of T4 DNA ligase (NEB) in total volume of 20 uL, and was 
allowed to incubate at room temperature O/N. After approximately 18 hr o f incubation, T4 DNA 
ligase was heat-inactivated at 65 °C for 20 min. 1 U each of BlpI (NEB) and PstI (NEB) restriction 
enzymes were added to each ligation mixture to eliminate any remaining vector backbone, and 
the samples were incubated at 37°C for 2 hrs. 100 uL of Top 10 F’ Pilus E.Coli competent cells
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were transformed with the ligated samples according to standard protocol and plated onto LB- 
Amp plates for O/N incubation at 37°C. Plasmid DNA from any observed colonies was isolated 
through a boiling mini-prep procedure, then digested with Apal and EcoRI restriction enzymes to 
screen for positive clones. The plasmid DNA from those positive clones were then used for 
transformation and subsequently isolated through the QiaPrep Spin MiniPrep Kit from Qiagen. 
To confirm proper ligation of Flag-Plk4 or Flag-K41M into PCDNA4/TO vector, 300 ng of 
plasmid DNA samples from each successful clone, as determined by restriction digest, were sent 
to ACGT (Toronto, ON) for sequencing. Reactions were performed using standard forward CMV 
and reverse BGH primers, as well as customized primers designed specifically to sequence 
critical regions of the construct. (Appendix A).
Transient transfection and induction o f expression vector containing Flag-Plk4 and Flag-K41M 
T-REX™-293 cells (Invitrogen) were maintained in Dulbecco’s Modified Eagle Medium 
(D-MEM) supplemented with 10% fetal bovine serum, 2 mM L-glutamine, 1% Pen-Strep, 250 
ug/mL Gentamicin, 250 ug/mL Fungizone, and 5 ug/mL of blasticidin and stored in a 37°C and 
5% CO2 humidified incubator. Cells were then transfected with either PCDNA4/TO Flag-Plk4 or 
PCDNA4/TO Flag-K41M according to standard transfection protocol as stated above. 24 hrs 
post-transfection, tetracycline at a final concentration of 100 ng/mL was added to the cells to 
induce expression of PCDNA4/TO-Flag Plk4; a plate of non-induced, transfected cells was also 
maintained as a control. After 18 hrs, cells were lysed and subjected to SDS-P AGE and Western 
blot analysis as previously described.
Determination o f selective antibiotic sensitivity
Optimal levels of Zeocin antibiotic required to eradicate untransfected host cells were 
determined by subjecting cells to a range of concentrations. Seven plates of T-REx™-293 cells 
were each seeded to 25% confluency and maintained in complete medium containing either 0, 50,
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125, 250, 500, 750, or 1000 pg/ml Zeocin™. Media was replenished every 3 days and cell 
survival was monitored every 24 hours. After seven days, the number o f viable cells maintained 
in each Zeocin test plate was counted, and the appropriate concentration o f antibiotic that 
inhibited cell proliferation was determined.
Selection o f stable integrants
Once successful transfection and induction of the PCDNA4/TO-Flag hPlk4 construct was 
attained, the protocol was repeated to begin selection of the stable integrants and to establish a 
stable cell line. Again, T-REx™-293 cells were maintained in complete DMEM containing 5 
ug/mL blasticidin but without Zeocin. 24 hours following transfection, the cells were washed 
once with Hank’s Balanced Salt Solution (HBSS) and fresh medium was added. 48 hours after 
transfection, the cells were either split and seeded to 25% confluency in complete media now 
containing 250 ug/mL of Zeocin, or were just replenished with the selective media depending on 
cell confluency. Fresh, selective media was added every three days to maintain antibiotic potency. 
When distinct cellular foci were observed, these colonies were scraped, trypsinzed, and 
transferred to 6.4 mm cell culture plates and allowed to proliferate. These original foci were 
subsequently expanded onto 14 mm, 31 mm, and eventually 100 mm dishes. 100 ng/mL of Tet 
was added to the stably-transfected cells to induce transcription o f the Flag-Plk4 and Flag-K41M 
genes and assayed for gene expression; a plate of non-induced stable transfectants was included 
in the analysis. Positive clones were then propagated to make frozen stocks.
Co-immunoprecipitation of Plk4 with putative interacting proteins
6 ug of Flag-Plk4 constructs were transfected into HEK-293 cells plated at a density o f 1 
x 106 cells per 100 mm dish. Various Flag-tagged constructs were tested, including wildtype 
(Flag-Plk4), kinase dead (Flag-hK41M and Flag-154N), kinase active (Flag-T170D), polo box
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Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
41
only (Flag-PB), Plk4 minus polo box (Flag-APB), and cryptic polo box only (Flag-Rl) constructs. 
Flag-hYVHl, a human protein phosphatase[PC4], was used as a negative control. Approximately 
18 hrs post-transfection, cells were lysed and 1 mg of protein lysates was incubated with 1 ug of 
the antibodies listed in Appendix B. 60 uL of a 1:5 slurry of Protein G Sepharose 4 Fast Flow 
beads (Amersham Biosciences) diluted in TNT buffer (50mM Tris-Cl, 100 mM NaCl, 1% Triton- 
X) was added to each sample and incubated for 45 min with gentle rocking. Samples were spun at 
4000 x g in a cold microcentrifuge for 1 min, and the beads were washed three times with TNT 
buffer. Samples were boiled for 5 min following the addition of loading buffer, and were 
separated through SDS-PAGE. Western blot analysis was performed using anti-Flag primary 
antibody diluted in TBST (1:10,000) for 1 hr at room temperature, and anti-mouse or anti-rabbit 
(1:60,000) secondary antibody for 45 min. Proteins were subjected to chemiluminesence for 
visualization and analysis.
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CHAPTER V 
RESULTS
Chk2 interacts with Plk4
On the basis that Chk2 is a physiological substrate of Plkl and Plk3, this study attempted to 
investigate if Plk4 shares a physical association with this DNA-damage checkpoint kinase. 
Tsetkov et al (2003) first reported a functional interaction between Plkl and Chk2 based on their 
overlapping subcellular localization patterns to the centrosomes and midbody during mitosis. Their 
data showed that Plkl overexpression in the absence of genotoxic stress enhanced T68 
phosphorylation of Chk2 at these critical mitotic structures, pointing to a role of Chk2 outside of 
the context of DNA damage. Additionally, Bahassi and co-workers (2006) revealed that Chk2 is 
phosphorylated at S73 and S62 residues by Plk3 as well, a modification that facilitates Chk2 
phosphorylation by ATM in response to DNA damage (Bahassi et al, 2006). [H5] To offer a 
preliminary assessment of Plk4’s association with Chk2, full length, truncated, and mutant forms 
of human Flag-Plk4 were transiently overexpressed in HEK-293 cells. Specifically, Flag-Plk4, 
Flag-K41M, Flag-154N, Flag-T170D, Flag-APB, Flag-Rl, Flag-PB, and Flag-hYVHl constructs 
were utilized for transient transfection, all of which are depicted in Figure 4 (except Flag-hYVHl). 
A more thorough characterization of the Plk4 mutant and deletion constructs will be provided in 
later sections. Originally, mouse fibroblast 3T3 cells were utilized as an expression system for the 
Plk4 constructs, however, were observed to produce lower transfection efficiencies relative to the 
HEK-293 cells (data not shown). Hence, future experiments requiring overexpression of Plk4 
were performed in the human embryonic kidney cell line. Following transfection and the 
allowance for expression of the Flag-tagged constructs mentioned above, cells were lysed and a 
small fraction of the collected proteins, both endogenous and overexpressed, were separated by 
SDS-PAGE; non-transfected cells were included as a negative control. Subsequently, Western 
blot analysis with an anti-Flag M2 monoclonal antibody (mouse) (Sigma) was performed to
42
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T170D
Fig. 4. Schematic representation of Plk4 constructs used in co-immunoprecipitations. Plk4
consists of a Ser/Thr kinase domain (KD) in the N-terminus, a polo-box region (pb) in the C- 
terminus, as well as a region defined as a ‘cryptic pb’ (cry-pb) upstream of pb. Cry-pb and pb are 
said to participate in the self-association of Plk4. The constructs were expressed individually in 
HEK-293 cells as fusion proteins in frame with an N-terminal with a 3X Flag-tag (Sigma). 
Numbers indicate the amino acid position defining the specified region. Asterisks represent the 
relative position of the single amino acid changed to generate a kinase-defective (D154N, K41M) 
or kinase-activating (T170D) mutant.
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confirm that transient transfection was successful. The presence of a positive band of the 
appropriate size in the lanes corresponding to transfected cells, verified that consistent and 
efficient expression of the Flag-tagged protein had occurred. (Figure 5 A, upper panel). No band 
was detected in the lane containing non-transfected cells, confirming that the observed bands in 
fact depicted the overexpressed protein and not non-specific, endogenous protein (Figure 5A, 
upper panel, ‘cells’ lane). Upon verification that the various Flag-tagged proteins were indeed 
expressed at effective levels, co-immunoprecipitation assays with the remaining lysate sample 
were performed using antibodies specific for the putative interacting partners. The rationale for 
this approach was that that if any Plk4 protein normally interacts with a candidate partner in cells, 
it could theoretically remain in contact with Plk4, be co-immunoprecipitated, thus pulling Plk4 
down with it, and later detected upon immunoblotting with an anti-Flag antibody. Co- 
immunoprecipitation experiments were performed using an anti-Chk2 monoclonal antibody 
(mouse) (Sigma.) Monoclonal antibodies were utilized when possible in co-immunoprecipitation 
experiments to ensure targeting of only a single epitope, thereby decreasing the chances of non­
specific binding. In addition, precipitated proteins were washed at minimum three times with 
nonionic-detergent-containing buffers (1% Triton-X) to obtain the cleanest sample of the 
immunoprecipitated proteins. Western blot analysis with an anti-Flag M2 monoclonal antibody 
(Sigma) confirmed the existence of an interaction between Chk2 and various Flag-tagged Plk4 
constructs. Specifically, full length Flag-Plk4, Flag-D154N and Flag-K41M (both kinase 
defective mutants) as well as Flag-APB (which lacks the conserved PB in the C-terminus) all co- 
immunoprecipitate with Chk2 (Figure 5A &B, lower panels). Flag-T170D, which contains a 
kinase activating mutation in the T-loop, also displays a physical interaction with Chk2 (Figure
44
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. Fig. 5. Co-immunoprecipitation of Chk2 and Plk4. A C. HEK-293 cells were transiently 
tranfected with the expression plasmid encoding Flag-tagged domain specific Plk4 constructs. 18 h 
post-transfection, whole cell lysates were prepared and immunoprecipitated (IP) with monoclonal 
anti-Chk2 antibodies (Sigma). Whole cell lysates and IPs were immunoblotted (IB) with 
monoclonal anti-Flag antibodies to confirm expression of the Flag-tagged proteins. Flag-hYVHl 
was used as a negative control. D. The blot was stripped and re-probed with an anti-Chk2 antibody 
to confirm equal levels of protein in each lane. Light chain immunoglobulins (IgG) are shown to 
verily that equal amounts of antibody were added to each sample
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5A, lower panel). In other Plk members, the polo box has been characterized as a binding region 
for substrate proteins, enabling proper subcellular localization of the protein (Lowery et al, 2004; 
Elia et al, 2003). Therefore, in order to determine whether the polo box region is critical for 
interaction in Plk4, cells were transiently transfected with Flag-PB, which encodes only the polo 
box region of Plk4. Immunoblotting confirmed that Chk2 does not interact with the polo box of 
Plk4. (Fig. 5C, lower panel, ‘Flag-PB’ lane). Similarly, Flag-Rl, which contains the region 
encoding the cryptic polo box of Plk4, also does not co-immunoprecipitate with anti-Chk2 
(Figure 5C, lower panel). To strengthen the findings that the observed co-immunoprecipitations 
indeed represented bona fide  physical interactions between Chk2 and Plk4, the experiments were 
performed at minimum three times, and each repeat was shown to produce identical results to 
what was originally observed (replicate experiments not shown). In addition, a Flag-tagged 
protein unrelated to Plk4 called Flag-hYVHl was incorporated as a negative control. hYVHl is a 
41 kDa dual-specificity protein-tyrosine phosphatase that is the human counterpart to YVH1 
protein found in the budding yeast Saccharomyces cerevisiae (Muda et al, 1999). The Flag- 
tagged hYVHl construct was a generous gift to the Hudson Lab by Dr. Otis Vacratsis (Dept, of 
Biochemistry, University of Windsor, ON). Flag-hYVHl was also overexpressed in HEK-293 
cells and subjected to co-immunoprecipitation assays with anti-Chk2 antibody but did not show a 
physical association similar to Flag-Plk4 (Figure 5A-C, ‘Flag-hYVHl’ lanes). This finding 
enhances the significance of the interaction observed between wildtype and mutant Plk4 with 
Chk2, indicating that the antibody was not binding non-specifically or through the FLAG epitope. 
Furthermore, the blot exhibited in Figure 5A was subject to antibody stripping as described in 
Materials and Methods, then re-probed with anti-Chk2 antibody at a recommended dilution of 
1:8000. This was done to ensure that equal levels of Chk2 protein were present in each sample, 
thereby eliminating the possibility that the negative results observed in the ‘cells only’ and ‘Flag- 
hYVHl’ lanes were simply due to reduced amounts of precipitated Chk2 protein. After stripping 
the blot, but prior to re-probing with anti-Chk2, chemiluminesence was performed to ensure that
49
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the stripping protocol was indeed effective and that no remaining signal could be detected (data 
not shown). Subsequent immunoblotting with anti-Chk2 antibody verified that each lane was 
loaded with equal levels of immunoprecipitated Chk2 protein, therefore suggesting that the bands 
originally observed were in fact due to a bona fide  physical association between Plk4 and Chk2 
(Figure 5D).
ATM interacts with Plk4
ATM is an upstream checkpoint kinase that initiates a signaling cascade leading to cell 
cycle arrest in response to ionizing radiation (IR) (Rotman and Shiloh, 1999). Upon triggering of 
ATM activity by damage-sensing proteins, the signal is then amplified to downstream[H6] kinases 
such as Chkl and Chk2, resulting in their phosphorylation and subsequent activation (Zhou and 
Elledge, 2000). Van Vugt et al (2001) provided evidence that Plkl kinase activity is reduced in 
response to adriamycin-induced DNA-damage, and that this catalytic suppression is mediated by 
ATM. When expressed in ATM-deficient cells, Plkl was no longer inhibited and its kinase activity 
remained deregulated. No defined role of Plk4 has thus far been established with respect to the 
DNA-damage response. This study attempted to provide insight on how Plk4 may participate in 
signal transduction pathways involving ATM by first examining if these two proteins can 
physically interact. Whole cell lysates obtained from HEK-293 cells were transiently transfected 
with various Plk4 constructs and 18 hrs post-transfection an anti-ATM monoclonal antibody 
(mouse) (Sigma) was used in co-immunoprecipitation assays; subsequent immunoblotting with 
anti-Flag (Sigma) confirmed an association between these two proteins. In addition to full-length 
Plk4, various deletion and point mutants were also overexpressed to help characterize which 
domains are critical for interaction. Pull down assays revealed that Flag-Plk4, Flag-K41M and 
Flag-T170D all interact with ATM, as evidenced by their co-immunoprecipitation (Figure 6A, 
lower panel). Additionally, Flag-D154N and Flag-APB can also interact with endogenous ATM
50
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protein (Figure 6B, lower left-hand panel). Although Flag-PB did not pull down with the anti- 
ATM antibody, the construct expressing the cryptic polo box of Plk4 (Flag-Rl) did exhibit an 
interaction (Figure 6B, lower right-hand panel). Flag-hYVHl, expressed as a negative control 
vector, did not co-immunocprecipitate with ATM. (Figure 6 A & B, lower panels,)
ATR interacts with Plk4
ATR is a phosphoinositide kinase structurally-related to ATM that also shares common 
functions in the response pathway to genotoxic stress, such as the phosphorylation and activation 
of tumor suppressors p53 and BRCA1 (Zhou and Elledge, 2000). ATR, however, appears to 
mediate repair of lesioned DNA in response to ultraviolet radiation (UV) rather than ionizing 
radiation (IR), the primary instigator of ATM activity (Van Vugt et al, 2001). ATR has also been 
recognized as a potential suppressor of Plkl kinase activity following DNA-damage caused by UV 
irradiation (Van Vugt et al, 2001). Evidence showed that Plkl activity was still attenuated in UV- 
treated ATM - / -  cells, suggesting the presence of ATR was able to assume the inhibitory role. 
Following the addition of caffeine, however, which blocks activity of ATM/ATR in the DNA- 
damage response, Plkl kinase activity was no longer reduced (Van Vugt et al, 2001). Given the 
evident correlation between ATR and Plkl activity, this study analyzed the possibility of a 
putative relation between ATR and Plk4. Therefore, to determine if Plk4 can interact with ATR in 
vivo, various constructs encoding wildtype Plk4 as well as mutated and deleted forms, were 
expressed in HEK-293 cells. Co-immunoprecipitation with a polyclonal anti-ATR antibody 
(mouse) (Calbiochem) was performed on lysates obtained from these cells 18h after transfection. 
Western blotting with the anti-Flag antibody revealed any potential interactions between ATR and 
Plk4. Full length Flag-Plk4, kinase dead Flag-K41M, and kinase active Flag-T170D all co-
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Fig. 6. Co-immunoprecipitation of ATM and Plk4. A & B. HEK-293 cells were transiently 
tranfected with the expression plasmid encoding Flag-tagged domain specific Plk4 constructs. 18 
h post-transfection, whole cell lysates were prepared and immunoprecipitated (IP) with 
monoclonal an anti-ATM antibody (Sigma). Whole cell lysates and IPs were immunoblotted (IB) 
with a monoclonal anti-Flag antibody to show expression of the Flag-tagged proteins. Flag- 
hYVHl was used as a negative control. Light chain immunoglobulins (IgG) are shown to verify 
equal amounts of antibody were added to each sample
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immunoprecipitate with ATR (Figure 7). Steven Petrinac of Dr. Hudson’s lab (University of 
Windsor, ON) followed this experiment by performing co-immunoprecipitations with anti-ATR on 
lysates obtained from Flag-Plk4, Flag-154N, Flag-APB, Flag-Rl, Flag-PB, and Flag-hYVHl 
overexpression; his results indicate that Flag-154N and Flag-APB show an interaction with ATR, 
while Flag-PB, Flag-Rl and Flag-YVHl do no show up in co-immunoprecipitates with ATR (data 
not shown).
Plk4 does not interact with the tubulin proteins. BRCA2. or Rb
It has been shown that Plk family members can interact with common proteins resulting 
in either similar or opposing effects on that substrate’s regulation. Many of these targeted proteins 
have been linked to regulating various aspects of mitotic progression and in mediating DNA- 
damage responses. Plkl, for example, has been shown to physically associate with a- and P- 
tubulin, the monomeric subunits that comprise the microtubules of the mitotic spindle, as well as 
y-tubulin, which enables the microtubules’ nucleation and polar orientation (Feng et al, 2001). It 
was found that Plkl exists in a stable complex with the tubulins and that during mitosis, can 
phosphorylate the proteins, suggesting a role in regulating microtubule dynamics and spindle 
assembly. In addition, the breast cancer susceptibility protein BRCA2, an essential protein in 
repairing DNA double-strand breaks and preserving chromosomal stability, has also been found to 
be a substrate of Plkl, and that its phosphorylation is enhanced by mitotic progression but 
inhibited by DNA damage (Lee et al, 2004). Retinoblastoma protein (Rb) is a crucial cell cycle 
regulator at the G1 restriction point of the cell cycle whose inactivation can lead to uncontrolled 
proliferation (Wiman, 1993). Gunawardena et al (2004) demonstrated that Plkl is regulated by the 
Rb tumor suppressor pathway and that activation of Rb pocket proteins p l07/pl30 suppresses Plkl 
activity. Since the tubulins, BRCA2, and Rb have been demonstrated to associate with Plks, each
54
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Fig. 7. Co-immunoprecipitation of ATR and Plk4. HEK-293 cells were transiently tranfected 
with an expression plasmid encoding Flag-tagged domain specific Plk4 constructs. 18 h post­
transfection, whole cell lysates were prepared and immunoprecipitated (IP) with polyclonal anti- 
ATR antibodies (Calbiochem). Whole cell lysates and IPs were immunoblotted (IB) with 
monoclonal anti-Flag antibodies to show expression of the Flag-tagged proteins. Flag-hYVHl 
was used as a negative control. Light chain immunoglobulins (IgG) are shown to verify equal 
amounts of antibody were added to each sample.
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with unique consequences, these proteins provide a basis for which to ascertain putative 
interacting partners for Plk4.
In an attempt to identify potential interacting partners with Plk4, various Flag-tagged 
constructs encoding the protein as represented in Figure 4 were transiently transfected into HEK- 
293 cells. Lysates obtained from transient overexpression of full-length, truncated, and mutant 
forms of Flag-Plk4 were then used in co-immunoprecipitation experiments with the following 
antibodies: monoclonal anti-a-tubulin from mouse {Sigma), monoclonal anti-y3-tubulin from mouse 
(Sigma), monoclonal anti-y-tubulin from mouse (Sigma), polyclonal anti-BRCA2 from rabbit 
(Sigma), and monoclonal anti-Rb from rabbit (Sigma). Western blot analysis with anti-Flag M2 
monoclonal antibody (Sigma) indicated that no physical interaction was detected between any of 
the Plk4 constructs and these candidate interacting partners (data not shown).
Establishment of a stable cell line for inducible Plk4 expression.
Creation o f PCDNA4/TO Flag-Plk4 and PCDNA4/TO Flag-K41M vector
To establish cell lines that stably express wildtype and kinase-dead Plk4, Flag-tagged 
constructs encoding these proteins first had to be released from their existing vector for eventual 
sub-cloning into the PCDNA4/TO (Invitrogen) expression vector. Plk4 and its kinase-defective 
counterpart K41M were originally cloned into separate p3XFlag-CMV™-7.1 Expression Vectors 
(Sigma) through a BamHI site located within the multiple cloning region (Figure 8A & B). These 
constructs were designed and created by Dr. Hudson and co-workers (Samuel Lunenfeld 
Research Institute of Mount Sinai Hospital, Toronto, ON). To facilitate the introduction of the 
Flag-tagged gene encoding wildtype and kinase dead Plk4 into the inducible expression vector, 
mutagenic primers were first designed against Flag-Plk4 and Flag-K41M. These synthetic, 
oligonucleotide primers were so designed that they would mutate three nucleotides within the six- 
base-pair region‘TTTAGT’ in to ‘CTTA/4<j’, which corresponds to an
56
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Flag-K41M
3X Flag-Plk4
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Fig. 8. A & B. Schematic diagrams of 3X Flag-Plk4 and 3X Flag-K41M constructs. Selected 
key components of the Vectors are depicted. Base pairs 877-3999 (red arrow) represent the region 
encoding Flag-Plk4 (A) (wildtype) or Flag-K41M (B) (kinase-dead) protein. P cm v  is a 
cytomegalovirus promoter that regulates transcription of the Flag-Plk4 and Flag-K41M genes.' 
The ampicillin gene confers antibiotic resistance to the vector allowing for its selection.
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Aflll restriction site (Figure 9A). PfuTurbo1 DNA polymerase and the QuikChange Site-Directed 
Mutagenesis method (Stratagene) were utilized in a polymerase chain reaction (PCR) that would 
extend the mutagenic primers and replicate the parental plasmid strand. After being subject to 
PCR, the product was digested with Dpnl enzyme, which specifically recognizes methylated, 
parental DNA and thus enables the selection of newly-synthesized, mutated DNA (Nelson and 
McClelland, 1992). It is worthwhile to mention that the A flll site was introduced 25 base pairs 
upstream of the ‘Met’ start site of the 3X Flag epitope in Flag-Plk4 and Flag-K41M vector 
(Figure 10). This was done to ensure that Plk4 and K41M retained the Flag tag when released 
from their original vectors, enabling them to be utilized in future experiments that may require 
immunoprecipitation of the protein with a commercially-available antibody after sub-cloning; 
PCDNA4/TO inducible expression vector itself does not encode a fusion tag that may be 
exploited in such a manner. Once the replicated DNA containing the A flll site was selected for, it 
was transformed into E. coli cells in order to propagate the vector, which was then purified 
through a standard boiling mini prep procedure. Restriction analysis o f the DNA with A flll and 
Apal enzyme (NEB) produced a 3221 bp and 4925 bp digest product, verifying the A flll site was 
properly introduced (Figure 9B). Following confirmation that the new site was indeed present, the 
Flag-Plk4(4/7Z/) and Flag-K41M(Aflll) vectors were again propagated and purified through a 
plasmid maxi prep kit (Qiagen). The resultant plasmid DNA was subsequently cut with A flll and 
Smal in order to extricate the Flag-tagged genes. The fragments were then ligated into the 
inducible expression vector PCDNA4/TO (Invitrogen) that would eventually be used for 
establishing the stable cell lines; the multiple cloning site contained recognition sequences for 
A flll and EcoRV, which were both exploited to facilitate the introduction o f  the newly-released 
Flag-Plk4(4/W7) and Flag-K41M(4/7//) segments (Figure 11). Ligation reactions were performed 
in ratios of 3:1 and 1:1 of insert:vector to maximize the potential of successful cloning. After 
transformation of the ligation mixtures, plasmid DNA isolated from numerous colonies was 
subjected to restriction digest with Apal and EcoRl enzymes; successful clones were found to
58
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3X FLAG-Plk4
7747 bp
CAGAGCTCGTTTAGTGAACCGTCA
Site-Directed Mutagenesis
Plk4Sma I (4088)
CAGAGCTCG"TTA»CGGAACCGTCA
B
5000 bp *  
4000 bp * 
3000 bp
- 4563 bp 
-3184 bp
Fig. 9A &B. A, Schematic diagram of 3X Flag-Plk4 vector with A flll recognition site. The
3X Flag vectors (Sigma) encoding either Plk4 or K41M (kinase dead) were subjected to site- 
directed mutagenesis using Pfu polymerase (Stratagem). An A flll restriction site (CTTAAG) was 
introduced at position 904 of the Flag vector to facilitate the subcloning o f Flag-Plk4 or Flag- 
K41M into the inducible expression vector PCDNA4/TO (Invitrogen). The position of the Smal 
restriction site is also indicated and was used, in addition to the A flll site, for diagnostic digests of 
the PCR product. The correct restriction digest yielded a 4563 bp and a 3184 bp product.
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8 5 3  GCAAATGGGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGrTTAGTGjAACCGTCAG
ForPFU
9 2 0  AATTAACCATGGACTACAAAGACCATGACGGTGATTATAAAGATCATGACATCGATTACAAGGATG 
------
98  6 ACGATGACAAGCTTGCGGCCGCGAATTCATCGATAGATCTGATATCGGTACCAGTCGACTCTAGAGG
1 0 5 3  a t c c c c c g g a g a a c c c a g g c c a g a g c c t g g a a a t a t g g c g a c c t g c a j c g g g g a g a a g a t c g a g g a  
1 1 1 9  t t t t a a a g t t g g a a a t c t g c t t g g t a a a g g a t c a t t t g c t g g t g t c t a c a g a g c t g a g t c c a t t c a
Fig. 10. Partial nucleotide sequence of 3X Flag-Plk4. The region corresponding to positions 
853-1185bp of the 3X Flag-Plk4 construct are represented. The thick, bolded arrow indicates the 
binding region of only the forward mutagenic primer ‘ForPFU’ utilized in the QuikChange Site- 
directed mutagenesis reaction {Stratagem) (Reverse primer not shown). The nucleotides bolded 
in red correspond to the region targeted for mutation, transforming the six-base pair region 
(boxed area) into an Aflll restriction site. Highlighted yellow is the ATG start site of the 3X Flag 
epitope, indicating its close proximity to the intended Aflll restriction site to be utilized for 
extricating the Flag-Plk4 and Flag-K41M gene for sub-cloning. The region shaded grey indicates 
the initial region encoding the Plk4 protein. Sequence is read 5’ ->3’.
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Afll l
(904) MCS
FLAG-Plk4-Aflll PCDNA4/TO
7747 bp 5078 bp
Plk4Sma I 
(4088)
♦ ♦
■ Restriction digest and 
#  ligation
..EcoRI (1008)
PCDNA4/TO-FLAG Plk4'
7747 bp
Flag-Plk4
A pal (4125)
EcoRI (3234)
Fig. 11. Schematic representation of the subcloning of Flag-Plk4-v4/7// into the 
PCDNA4/TO vector. Restriction sites in red indicate those used for subcloning reactions; sites in 
green represent those used for diagnostic purposes. Numbers in brackets indicate the relative 
positions of the restriction sites on the vector.
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generate a 5089 bp, 2226 bp, and 891 bp band (Figure 12), indicating that Flag-Plk4 and Flag- 
K41M were properly ligated in frame upon cloning. Samples from both clones were then sent to 
ACGT Corporation (Toronto, ON) for sequencing of the entire vector; results showed that both 
Flag-Plk4 and Flag-K41M were cloned in proper frame with the PCDNA4/TO vector (Figure 13),
1) Transfection o f PCDNA4/TO-Flag-Plk4 and PCDNA4/TO-Flag-K41M
The newly-synthesized PCDNA4/TO-Flag-Plk4 and PCDNA4/TO-Flag-K41M vectors 
were then transiently transfected into the T-Rex™ 293 cells (Invitrogen), which stably express a 
PCDNA6/TR vector (Figure 14). The plasmid contains a gene that encodes a tetracycline 
repressor (tetR), which is under the control of a CMV promoter, as well as a gene for blasticidin 
antibiotic resistance . When cultured in the presence of blasticidin-containing media, the T-Rex™ 
293 cells maintain the PCDNA6/TR vector and continually express tetR. Because the 
PCDNA4/TO vector contains two tetracycline operator 2 (Tet02) sites within the human 
cytomegalovirus immediate-early (CMV) promoter, expression of the gene of interest (ie. Flag- 
Plk4 and Flag-K41M) can be repressed by binding of tetR protein expressed from PCDNA6/TR 
(Yao et al., 1998). Transfected cells were grown in the presence of Zeocin™ antibiotic 
{Invitrogen) in order to select for successful integrants of the inducible expression vector. 
Zeocin™ is a broad-spectrum antibiotic derived from a family of related bleomycin/phleomycin- 
type antibiotics isolated from Streptomyces, and exhibits strong toxic effects against bacteria, 
fungi (including yeast), plants, and mammalian cells (Baron et al., 1992; Drocourt et al., 1990; 
Mulsant et al., 1988; Perez et al., 1989). In this study, Zeocin™ is used as a selection agent for 
non-resistant cells, thus allowing propagation of those cells that effectively retained the 
PCDNA4/TO-Flag Plk4 and PCDNA4/TO-Flag-K41M vectors. A Zeocin sensitivity assay was 
performed to determine the minimum concentration needed to eradicate untransfected cells, and 
was found to be 250 pg/mL. Sensitive cells exhibited abnormal morphology upon exposure to 
Zeocin, as well as an increase in size, and the formation of large vesicles and the appearance of
62
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holes within the cytoplasm. Prolonged Zeocin exposure (~ 7-10 days) caused any sensitive cells 
to eventually disintegrate due to a complete breakdown of cellular structures such as the 
endoplasmic reticulum, Golgi apparatus, and plasma membrane. Isolated colonies of those stable 
transfectants were then picked and subcultured onto 6.4 mm plates, and eventually propagated 
onto 14 mm, 31 mm, and 100 mm dishes. Cells required passaging every 3-5 days. 17 clones of 
PCDNA4/TO-Flag-Plk4 and 23 clones of PCDNA4/TO-Flag-K41M were competent to reach the 
100 mm dish stage. Before expression of PCDNA4/TO-Flag-Plk4 and PCDNA4/TO-Flag-K41M 
could be quantified, the CMV promoter region controlling transcription of both genes’ needed to 
be derepressed. Addition of tetracycline (Tet) to the medium would cause the TetR homodimers 
that were bound to the operator sites of the expression vector to change conformation. Upon 
modification of the repressor protein, it would no longer be able to block expression of the Flag- 
Plk4 and Flag-K41M gene, thus allowing for their transcription to occur. Initially, lOOng/mL of 
Tet was added to the media of each of the clones to induce gene expression, and incubated for 18 
hrs prior to lysing cells. Proteins obtained from lysed samples were separated through SDS- 
PAGE and subjected to immunoblotting. Of the 40 clones that were tested in total for both 
wildtype and kinase-dead Plk4, two clones for each construct were chosen (designated Plk4-E 
and Plk4-F; K41M-B and K41M-S) that effectively produced a protein of -100 kDa, 
corresponding to the protein size of Flag-Plk4 and Flag-K41M (Figure 15, upper panel). Non­
transfected (+Tet and -Tet) as well as transfected (-Tet) T-Rex™ 293 cells were used as negative 
controls and in fact did not express a 100 kDa protein that would indicate the presence of Flag- 
Plk4 or Flag-K41M. These results provide further validity that the observed proteins in the 
transfected, induced lanes were Flag-Plk4 and FIag-K41M. Furthermore, immunoprecipitation of 
the lysates and subsequent immunoblotting with monoclonal anti-Flag M2 antibody (mouse) 
(Sigma) confirmed the observed bands were in fact the desired Flag-tagged protein and not a non­
specific band coincidentally running at the same size (Figure 15, lower panel). After the
63
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Fig. 12. Diagnostic restriction digests of ligated PCDNA4/TO-Flag-Plk4 and PCDNA4/TO- 
Flag-KIM plasmid DNA. After the introduction of the A flll restriction site, Flag-Plk4 and Flag- 
K41M were each digested with 1 U of A flll and Smal (NEB), while PCDNA4/TO was subjected 
to Aflll and EcorV (NEB) digestion. Ligation reactions in both 3:1 and 1:1 ratios of insert:vector 
were tested and subsequently transformed into E. coli cells. Plasmid DNA was isolated and 
digested with Apal and EcoRI (NEB) to confirm proper ligation of Flag-Plk4 and Flag-K41M into 
the inducible expression vector. Digested products were run on a 1 % agarose gel, which indicated 
the presence of a 5089 bp, 2226 bp, and 891 bp fragment for each vector, as would be expected.
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Actual sequence —'VYISRAXPISDRDLPISDRDRilRARLVHRQIAKRRHPRCFDLKRRHRDRSSLRTLAFK 
Theoretical sequence WEVYISRA1PISDRDLPISDRDRRRARLVNRQIAKRRHPRCFDLRFRHRDRSSLRTLAFK
LKEPSEFTMDYKDHDSDYKDffDIDYKDDDDKLAMNSSIDLISVFVDSRGSFGEFRPEPG
IKEPSELTKDrKDHMSYKDHDIDyKDMSKLmHSSIDLISVFVDSRGSPGEPRPEPG
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
NMATCIGEKIEDFXVGNLLGKGSETUJVTfaAESIHIGIXVaiKMIDKKAJfi'KRGH’/^V Q NNKilOeEKIEDJiW^JLL^SFA^aAESlHTGLEVAIHXiaKKiUimttM^'.VgN
nTrrP^miPSTta::T.Yy^DSMYVmVI^ ga^ ^^ IJa^KPFSO«E^iiPl{HOE'^ fii^ F^SILEI.YKCTEDSMlTii^VI£Ki3?K3Ef3iRYLKI'!SV5[PFSFJ'.TE:<\RHnnHQ
IIIiaiLYLHSHGILHFiLlLSKLL-LTBlfl^IKIADS^ATCUQ^niEiG-iyiLCGTPN'flS
IIIGKLYUiSHGILt!RDL2LS}ILLLTBNKHIKIADFGLAIQL«HP!5S!-QiYTLC5TPNYI5
i£IAIRSMGIIS^ L^SC35FmiJ^PFDT3rVKHXU!KmftOYEK?rEL3IEJIKKXATB=M5LZ5!Tv^SL5GKr/TIiISI^Pri>IpmKIlHKt/,/IAD'(TK?IFLSIEAK
DLiaQX.LRRNPAI«LSl.S3VlMPnSSEK?SIK3EDLSTVEDSIDS<jiaTIST&ITASS3
DUHQLlBRBPAr«LSLSSVLIfflPreSRKSSTXSmCTVEDSTDaSHATISTAITASSS
TS1 SSSLPT»<RRLLrGQPLi»HE{Ki:VPPKaaSSI 5)F3SSSI>SKS m -QtfSK$ETS HSSRSR 
TSISGStFDKE&IAIGSPLFitKKIVITKHIGSTDFSSSG-lXiNSFYTSfRGil^ETSilSGRSR
VICg»2ZaraSRyi^PA?SSDe^SKB^J£^MaYIKERCH3ftEMLSVBKRS'3GGENEER 
i9I?PiSERPaSR213aJlYSSi»SSTSHR^2SQM{T?31iERCHSaEI«iSV3KBS3&3EHESa 
******************** *******•********-**** + *-************•* ******
Y S P T D H H A K i n i F F K E K T S S S S C r S F E R P n K H 2 f t L S N a L C P S S I P F P F A D ? T P Q T E T ' / ^ K 3 f
YSPT£aJKANIiyFn<EKISSSSGSEERK)lWfiM^tIHJiCPGKTPFPFADPXPQTETV^{5
I ! * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
Actual sequence rGHLQIH^aLRKTIEiDSISKW.DFftGHPDL.^OTSffilAK’IDXK'.’KKISDilS^JAHSVIQ:■ 
Theoretical sequence FGHLQIHMU^TEYDSISFKRDFQcHPDL^P^SKl^AKTOTKVKKIISDAS^AHSVKQ' 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *  * * * * * * * * * * * * * * * * * * * * * *
5!KIi3fY5fTALKSRP'SIIQviECVT5SDPLSEftSKTRGMEPP'5?SY>3’iRTLRSITSPL'VAHKLCJrr^ K^YK7ftLaSKTEri^CVTG5DFL3EQSKTRGHEPF5f>3Y^*RTLRSIT3PL‘VAHPX
**A!i***********?«ri*'** **********!»**■**** ****** *****************
KPIRQCT^IAWSILDSEHr^CVEtVIiYiSQEXV^Vl^ISSDQlXIXIYYPBSSRSFPL KPIRQKTKK^WSILDSEE'/rVZLVKEYASQEYVK^JLOISSDSHTillYYPNGGRSFPL 
*.*** *******'»•***'**** ******* ***■***.********'*•*****+****»* *******
AiJRPPSPIEWISP.YSFONLPEKYWRKYQYASRFVQLLRSEfSPKITYFTRYAKCSL^WSPADS.PPSnDNISRYSFD>0,EEKYi9RKrerA5RF'/!yiLRSKSPKIlYmYAKCIltiENSP
GADrEWrfSGrKIHKIEDFIQVISKTGKSYILKSESSrwrSLKE^iaiYKXaAHESgRlC^£&DFirt,^*?JYril?/lCI!JKTEDFIQ,/IESISK3YTt.kSES57^SiKEEXK4re^lS^SBRiG
LALESIISEEERKTRSAPFFFIIIGRKPGSISSHGlLSPPPSTOSHYFIRER&SniKiW SUlcSnSEEERKTR3APFFPIIISRKF5ST33PKAI^???S'^ )3NYKRDRASrNRSWM
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
HSDA3FT0SBI1.^Stfn’HESI.GLTITASSTDIS3HSl5CpCI.PKSAQLLKSVrVlQJV5WA 
HSDAS F I Q A F I I ^ S l^ T H E G I S m T  A5G3 D t ^ S i i B K l S f C S M ^ ^  ; :
T^-“SGAV»VOn'IDGSyLVV^ASVSSISYT3EIGCTYRYGB3IERLPDYII^<LQCtSSILTQT.TSfir^ /rjnJD^SQLWOAGVSSTSYTSPHGOIlRYi^ IEW.PDYIKCSaQa^Sn-
* * * * * * * * * * * * * * * * * * * * * * * + * * * * * * * * * * * * * * * * * * *
LM f'SHHHJFH-LKLLSDI-V— IIFLLTFK K K K K IL^W IPSSrV iA A R V -R A R lilPLI 
I4^F3NETPifFH-LKLLSDI-V— ITFLLIFK K K K K Tl^R IPSSIV aftA FV -R A R IO TLI 
* * * * * * * * * * >  * * * * * * *  * * * * * * * * * * * * * * * * * * * * * * * * * * * * *  * * * * * * * *
Fig. 13. Alignment of amino acid sequence of PCDNA4/TO-Flag-Plk4. After subcloning of 
Flag-Plk4 into the inducible expression vector PCDNA4/TO, the plasmid DNA was purified and 
sent to ACGT (Toronto, ON) for sequencing. Standard CMV and BGH primers, as well as 
customized primers, were utilized to fully sequence the entire region encoding Plk4. The resultant 
DNA sequence was inputted into a protein translation program, Expasy, in order to obtain the 
corresponding amino acid (AA) sequence. A bioinformatics program called Vector NTI 
(Invitrogen) was utilized to generate the theoretical DNA sequence that should be obtained 
following proper ligation of Flag-Plk4 into the PCDNA4/TO vector. This sequence was also 
translated and then aligned with the AA sequence obtained from ACGT. AAs are represented by 
their single letter codes. Asterisks indicate a matching residue. The region highlighted yellow 
represents the actual Plk4 protein sequence. Similar alignments were performed with 
PCDNA4/TO-Flag-K41M (data not shown).
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PCDNA6/TR
Fig. 14. Schematic representation of the PCDNA6/TR vector. Select key components of the 
vector are depicted. The TetR gene (bases 1684-2340) encodes the tetracycline repressor 
responsible for regulating transcription of the gene of interest when co-transfected with the 
PCDNA4/TO inducible expression vector. PCMV (bases 232-819) is the cytomegalovirus 
promoter which governs TetR transcription. Ampicillin (bases 5666-6526 on complementary 
strand) and blasticidin (bases 3782-4180) are genes that confer resistance to the plasmid and 
allow for its selection in the presence of these antibiotics.
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Fig. 15. Stable expression of Flag-Plk4 and Flag-K41M in T-Rex™-293 cells. T-Rex™-293 
cells (.Invitrogen) stably expressing a tetracycline repressor (Tet) were transfected with either 
PCDNA4/TO-Flag-Plk4 or PCDNA4/TO-Flag-K41M, which both contain Tet binding sites. 24 h 
post transfection, tetracycline was added at a final concentration of 100 ng/mL to induce 
expression of the gene. After 18 h, whole cell lysates were prepared, subjected to SDS-PAGE and 
then immunoblotted with an anti-Flag M2 monoclonal antibody (Sigma) to confirm stable 
expression of Flag-Plk4 and Flag-K41M (upper panel). Subsequently, an immunoprecipitation 
with an anti-Flag antibody (Sigma) was performed to confirm the observed bands were indeed 
overexpressed Flag-tagged proteins (lower panel).
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establishment o f  the successful clones, cells were propagated to generate frozen stocks for future 
use. As a supplementary experiment, various concentrations of tetracycline (0, 25, 50,100, and 
200 ng/mL) were administered to one clone (Plk4-F) to determine the optimal concentration to 
induce expression. After 18 h, cells were lysed and the proteins were separated through SDS- 
PAGE and subject to immunoblotting. Western blot analysis revealed that 100 ng/mL produced 
the highest level of induction for PCDNA4/TO-Flag Plk4 expression (Figure 16).
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Fig. 16. Optimizatipn' df PCDNA4/TO-Flag-Plk4-F gene expression. Once positive clones for 
Plk4 and K41M gene expression were obtained, one clone was chosen (Plk4-F) to assay for 
optimal tetracycline-induced expression. Varying concentrations of tetracycline were added to’ 
each plate (0, 10, 25, 50, 100, and 200 ng/mL) followed by induction o f protein for an 18 hr 
period. Cells were lysed, the proteins separated through SDS-PAGE, and then detected by 
Western blotting. A positive signal at 100 kDa corresponds to the expressed Flag-Plk4 protein.
o) o) m  e  c
c  c  c  o  o
o  LO o  o  o
T— CM in  T- CN
69
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
71
CHAPTER VI 
DISCUSSION
t A-'
Putative interacting partners of Plk4
The major goal of this study was to identify and characterize putative interacting partners 
for Plk4. Plk4 is the least well-characterized member of the mammalian Plks. The protein 
partners with which it physically and/or functionally interacts with in vivo, as well as the 
mechanisms by which it is regulated, still remain to be elucidated. Because Plk family members 
have been found to target the same or functionally-related proteins, thereby exerting either similar 
or opposing effects on the interacting partner, it was worthwhile to ascertain whether Plk4 also 
associated with these candidate proteins and, if they exist, to define the mode of these 
interactions.
A key area of interest wa6 the putative interactions of Plk4 with proteins involved in the 
the cellular response to DNA-damage. The Plks have been shown to be involved with the 
coordination o f  a multitude of protein pathways that function to induce cell cycle arrest, promote 
apoptosis or DNA repair. Checkpoints are implemented at the G l, S, or G2/M phases in order to 
halt further progression when activated and prevent lesioned DNA from being propagated, thus 
ensuring proper repair of damaged strands and promoting genomic stability. The earliest step in 
the pathway to DNA-damage repair is the detection of impaired DNA by sensor proteins, crucial 
initiators of the damage response whose identities currently remain elusive (Zhou and Elledge, 
2000). More extensively characterized are the transducer proteins, which function by relaying the 
initial signal detected by the sensor proteins, and the effector proteins, ultimately responsible for 
executing the response by arresting the cell cycle. Key transducers of the DNA-damage response 
include the phosphoinositide kinase homologs ataxia telangiectasia-mutated (ATM) and ATM- 
and Rad3-related (ATR), as well as the more downstream protein kinases Chkl and Chk2.
i.) Chk2 physically associates with Plk4
71
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
72
The results presented in this study provide novel evidence for Chk2 being an interacting
\
partner for Plk4, implicating a role of Plk4 in key DNA damage pathways. Chk2 is activated in 
cases of double-stranded breaks caused by ionizing radiation (IR), but is also induced upon 
ultraviolet exposure (UV) and treatment with the ribonucleotide reductase inhibitor hydroxyurea 
(HU) (Matsuoka et al, 2000). The Plks have been implicated as intermediary regulators in DNA- 
damage response pathways common to Chk2. Previously, Plkl and Plk3 were shown to 
phosphorylate Chk2 at distinct residues (Tsetkov et al, 2003; Bahassi et al, 2006). In the case of 
Plkl, Chk2 phosphorylation occurred at residues normally phosphorylated by ATM and ATR in 
the DNA-damage response (Thr-68 and Thr-26 or Ser-28), but in the case of Plkl modification of 
these residues occurred in the absence of DNA-damage at the centrosomes and midbody (Tsetkov 
et al, 2003). These findings suggest a role of Plkl and Chk2 in regulating chromosomal dynamics 
outside of the DNA-damage response. Similarly, Plk3 phosphorylates Chk2 at residues Ser-62 
and Ser-73, which results in the enhancement of DNA-damaged induced phosphorylation by 
ATM at Thr-68 (Bahassi et al, 2006). Upon mutation of Ser-73 to alanine in Chk2, Plk3 
phosphorylation at this site was prohibited, leading to a decrease in Chk2 activity, as well as an 
inability of the checkpoint kinase to be activated by ATM’s phosphorylation at Thr-68.
To further map out the region required for Plk4’s interaction with Chk2, full-length Plk4 
as well as deletion and point Plk4 mutants were expressed in HEK-293 cells, and the resultant 
lysates were subject to co-immunoprecipitation assays with anti-Chk2 antibody. Wildtype Plk4 
was found to associate with Chk2 as revealed by immunoblotting analysis (Figures 5A & B, 
‘Flag-Plk4’ lanes). The two kinase dead constructs utilized in the assays—D154N and K41M— 
were rendered catalytically-inactive through alteration of a charged residue (either Asp or Lys) to 
an uncharged one (Asn or Met) within the ATP-binding domain of Plk4; the resulting effect of 
this mutation is to incapacitate the enzyme from properly phosphorylating its substrate. Various 
point mutations in the kinase domain did not seem to hinder any interaction between the
72
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candidate protein and Plk4 (Figure 5A, lower panel, ‘Flag-K41M’ lane; Figure 5B, lower panel, 
‘Flag-154N’ lane) as evidenced by their co-immunoprecipitation. A previous study conducted by 
Tsetkov et al (2005) also showed that a kinase defective Plkl mutant was still able to pull down 
with Chk2. In addition, a study of the Plk homolog Plol in fission yeast showed that a kinase- 
dead mutant, as well as Plol lacking the entire kinase domain, were still able to associate with 
known interacting partners Cut23 and Dmfl/Midl (Reynolds and Ohkura, 2002). Additionally, 
co-immunoprecipitation studies with Plkl and the tubulin proteins showed that a kinase-dead 
Plkl mutant was greatly enriched in the tubulin immunoprecipitates (Feng et al, 1999). The 
results in this study imply that the kinase activity of Plk4 is not imperative for its binding to 
Chk2. A defective kinase domain does not preclude the possibility that these potential interacting 
partners may still be a substrate of Plk4; immunoprecipitation assays are limited in that they can 
demonstrate a physical interaction between two proteins, but fail to characterize the nature or 
consequence of that interaction. Therefore, further analysis on the interaction between Chk2 and 
Plk4 would be required to conclusively identify the manner in which the two proteins associate.
In addition to a catalytically-inactive mutant, a kinase-activating Plk4 mutant was also 
shown to co-immunoprecipitate with Chk2 (Figure 5B, lower panel, ‘Flag-T170D’ lane). Flag- 
T170D contains a point mutation in the T-loop activation domain of Plk4 that modifies a Thr at 
position 170 to an Asp; replacement of Thr by a charged residue mimics the effect of T-loop 
phosphorylation. Previous studies revealed that in Plkl, intramolecular association of the PBD 
with the T-loop in the kinase domain suppresses Plkl catalytic activity (Tsetkov et al, 2001). 
Phosphorylation of Thrl70 in the T-loop relieves the autoinhibitory effect of the PBD, resulting 
in a kinase that is hyperactive (Jang et al, 2001). Indeed, Swallow et al (2005) confirmed this 
mutation in Plk4 renders the kinase constituitively active. One explanation for the physical 
interaction that was observed with Chk2 is that a constitutively-active Plk4 mutant may indicate 
an inability of the kinase to dissociate from its targeted protein. This would cause a virtually
73
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permanent association between Plk4 kinase and its substrate that would be detected by a co-
immunoprecipitation experiment, as was observed in this study.
' \ 
Previous studies have defined the PB of Plk4 as a critical region for the formation of
intermolecular homodimers of the kinase (Leung et al, 2002); it is also an essential component to
the domain that enables proper subcellular localization of the protein. Pull down assays with only
the PB region of Plk4 did not show an interaction with Chk2, suggesting it may not be required
for their physical interaction in vivo (Figure 5C, lower panel, ‘Flag-PB’ lane). Indeed, deletion of
the PB of Plk4 did not affect the protein’s ability to bind to any of the proposed interacting
partners (Figure 5B, lower panel, ‘Flag-APB’ lane). A study conducted on Plkl and its interaction
with a-, P-, and y-tubulin, however, showed that deletion of the PB from Plkl did not
significantly affect its association with the tubulin proteins (Feng et al, 1999). These results
concur with the observations of this study, which confirmed that FLAG-APB maintained a
physical interaction with Chk2 despite the absence of the PBD. In a separate study, a yeast-two
hybrid assay was performed that revealed an interaction between full-length Plk2 and calcium-
and integrin-binding protein (CIB); the evidence showed that sole expression of the C-terminal
domain, which retained an intact polo-box and other conserved sequences, was no longer able to
physically associate with CIB (Ma et al, 2003). These results agree with the findings obtained in
this study that showed Chk2 did not pull down with the Flag-PB construct of Plk4. Some
contradictory evidence does exist, however, obtained from previous studies on other Plks, such as
the findings published by Reynolds and Ohkura (2003), which showed that mutations of
conserved residues within the PB region of Plol disrupted the association between this Plk
member and its potential interacting partners. Similarly, inactivating point mutations in the PBD
of Plkl also hindered its immunoprecipitation with Chk2, as well as with known substrates
Cdc25C and Mklp2, as demonstrated in previous experiments (Tsetkov et al, 2005; Elia et al,
2003; Neef at al, 2003). The fact that Plk4 was not able to associate with Chk2 when expressed
solely as the PB suggests that regions outside this conserved motif are necessary for their physical
74
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interaction. One possibility is that these kinases phosphorylate Plk4 within its catalytic domain; 
thus, the loss of this fundamental region from the Flag-PB construct would eliminate any 
potential for physical association. Perhaps Chk2 exists merely as an ‘adaptor’ protein rather than 
a direct substrate/kinase to Plk4. Therefore, regions outside the PB may act as attachment sites for 
these proteins; without these regions present, they cannot bind and recruit bona fide  
substrates/kinases of Plk4. Thus, the mechanism of interaction between Plk4 and these 
potentially associated proteins merits further investigation.
Plk4 is unique from the other Plk members in that it contains a single conserved PB, and 
a divergent PB region designated as the cryptic PB (cry-pb). Leung et al (2002) propose that the 
cry-pb and PB together are essential for Plk4’s self-association in vivo. Results indicate that the 
cry-pb alone does not pull down with Chk2 (Figure 5C, lower panel, ‘Flag-Rl’ lane), suggesting 
this region is not sufficient for interaction. Previous studies support the idea that the PB motifs 
individually expressed are not sufficient for proper function of the Plks, but rather the C-terminus 
expressed as a whole unit (ie. regions upstream of the PB, the linker region, as well as both PBs) 
that contributes to its phosphopeptide binding ability (Tsetkov et al, 2005). This may explain 
why Chk2 was not able to co-immunoprecipitate with only the cry-pb of Plk4, indicating a 
necessity of the other PBD components.
Reciprocal co-immunoprecipitations were also performed to confirm the validity of the 
interactions that were observed between Plk4 and Chk2, but unfortunately were unsuccessful. 
Originally, pull down assays were conducted by immunoprecipitating Chk2, followed by 
immunoblotting with an anti-Flag antibody to detect the presence of Flag-Plk4. Subsequent to 
immunoblot analysis, it was shown that wildtype, kinase-dead, kinase-active, and PB-deleted 
Plk4 proteins effectively co-immunoprecipitated with Chk2, as depicted in Figure 5A & B. 
Numerous attempts to detect an interaction by immunoprecipitating Flag-Plk4 constructs and 
probing with anti-Chk2, however, proved futile. Possible explanations for the observed 
phenomenon may be that endogenous Chk2 levels were too minimal to be co-immunoprecipitated
75
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with Plk4, making it difficult to experimentally capture a physical interaction between the two 
proteins. Originally, monoclonal anti-Chk2 antibody was employed to immunoprecipitate any 
endogenously-expressed Chk2 protein, while the overexpressed Plk4 was examined for a 
potential interaction. Conversely, the reciprocal experiment involved pulling down an already 
overexpressed Plk4 protein with a monoclonal anti-Flag antibody, then attempting to detect a 
potential association with endogenous Chk2. In the former case, both proteins are likely more 
abundant due to antibody-targeting of Chk2 coupled with the overexpression o f Plk4, relative to 
the latter case. Chk2 remains relatively inactive in the absence of DNA damage; only upon 
exposure to genotoxic stresses such as UV or IR does the kinase become activated upon 
phosphorylation by more the upstream checkpoint kinases ATM and ATR (Tsetkov et al, 2003). 
It is possible that inducing DNA-damage prior to co-immunoprecipitation assays would greatly 
enhance endogenous Chk2 levels, thereby increasing the likelihood that a physical association 
can be detected upon pulling down Plk4. In addition, a positive interaction result from 
overexpressing a tagged Chk2 construct and performing co-immunoprecipitations. with an 
antibody against endogenous Plk4 would also enhance the validity that Chk2 and Plk4 physically 
interact in vivo. Currently, however, no effective endogenous antibody for Plk4 exists, precluding 
a means of detecting Plk4 other than through an overexpression system.
ii) ATM physically associates with Plk4
As mentioned earlier, ATM is crucial for the initiation o f signaling pathways in 
mammalian cells following exposure to ionizing radiation (IR) and to other agents that introduce 
double-strand breaks into cellular DNA (Kastan and Lim, 2000). Upon activation, ATM triggers a 
signal transduction pathway that ultimately leads to repair of DNA lesions, one pathway being the 
phosphorylation of the tumor suppressor p53; this results in increased stability o f the protein and 
more pronounced transcriptional activity, eventually giving rise to a G1 cell-cycle arrest. (Zhou 
and Elledge, 2000). Additionally, activation of the checkpoint kinases Chk l and Chk2 by ATM is
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an intermediary step in the pathway leading to mending unstable DNA. Previous studies have 
provided evidence that ATM can mediate inhibition of Plkl in response to DNA damage (Van 
Vugt et al, 2001). It was shown that when ATM - / -  cells are exposed to the DNA-damaging 
agent adriamycin, Plkl is no longer effectively inhibited, implicating ATM as a key regulator of 
Plkl repression. In this study, similar co-immunoprecipitation experiments to those conducted 
with Plk4 and Chk2 were performed with ATM to determine if it also is a candidate interacting 
partner. Evidence showed that full-length Flag-Plk4, kinase-dead Flag-K41M and Flag-154N, and 
kinase-active Flag-T170D can all pull down with immunoprecipitated ATM (Fig. 6A & B, lower 
panels). One notable observation was that the kinase-active mutant of Plk4 showed higher levels 
of immunoprecipitated ATM protein relative to the other constructs (Figure 6B, lower panel, 
‘Flag-T170D’ lane). As mentioned earlier, Plkl kinase activity is suppressed by the 
intramolecular association of the PBD with the T-loop, and that phosphorylation of Thrl70 in the 
T-loop relieves the autoinhibitory effect (Tsetkov et al, 2001; Jang et al, 2001). It is possible that 
Plk4 experiences a similar effect and that release from autoinhibition upon a T170D mutation (as 
exhibited in the Flag-T170D construct) favours a more open structure o f Plk4. This in turn may 
facilitate its association with other proteins, and possibly explain why co-immunoprecipitation 
assays with ATM revealed a stronger interaction with the kinase-active Flag-T170D mutant of 
Plk4. Deletion of the PB did not hinder an interaction with ATM and Plk4, as was also observed 
with Chk2 (Figure 6B, lower left-hand panel, ‘Flag APB’ lane.). However, ATM was able to bind 
with Flag-Rl, the construct expressing the cry-pb of Plk4 (Figure 6B, lower right-hand panel, 
‘Flag-Rl’ lane). Conversely, Chk2 did not associate with the cry-pb. This indicates that the cry- 
pb region of Plk4 may be critical to its physical association with ATM, and suggests that Plk4 
may interact in a different manner with ATM than with Chk2. It would be interesting to observe 
whether expression of a deletion construct that lacks the cry-pb would preclude an interaction 
between Plk4 and ATM. A construct expressing Flag-Acry-pb was not available at the time 
experiments for this study were being performed, though a HEK-293 cell line stably expressing
77
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this protein is currently being developed by Doreen Ezeife (University of Windsor, ON).
Expression of this construct and co-immunoprecipitations with anti-ATM would confirm whether
' \  
or not this region is indispensable for associating with ATM.
iii.) ATR physically associates with Plk4
ATR is structurally similar to ATM, with a similar role in inducing a G2/M cell cycle 
arrest in cases of genotoxic stress, however is primarily triggered upon UV exposure rather than 
IR, which is the case with ATM (Van vugt et al, 2001). As with ATM, ATR was also found to be 
a direct regulator of p53 through its phosphorylation of the tumor suppressor, implying it is an 
important link between the DNA damage response and cell cycle arrest (Tibbetts et al, 1999). 
Van vugt and co-workers (2001) showed in their study that ATR mediates inhibition of Plkl in 
response to UV damage. In ATM - / -  cells that were subjected to UV treatment, Plkl activity was 
still suppressed, suggesting the presence of ATR was able to maintain its inhibition; however 
upon administration of caffeine, which blocks activity of ATM/ATR in the DNA-damage 
response, Plkl was no longer suppressed. This study found that full-length, kinase-dead, and 
kinase-active Plk4 all display a physical interaction with ATR Experiments were performed in the 
absence of UV damage, which is the key inducer of ATR activity; despite this fact, an association 
with Plk4 was still detected, indicating that that the interaction between ATR and Plk4 may not 
be entirely DNA-damage-dependent. These two proteins may form an association that maintains 
itself throughout the cell cycle and upon UV-induced damage, may alter their interaction with 
each other. The precise effects of genotoxic stress to the interaction between Plk4 and ATR 
remains to be elucidated.
As with Chk2, reciprocal co-immunoprecipitations were also attempted with ATM and 
ATR, namely by pulling down Flag-Plk4 and analyzing if ATM/ATR was able to co- 
immunoprecipitate with the targeted protein. Again, the co-immunoprecipitations performed in 
this manner were ineffective and no ATM/ATR protein was able to be detected by Western
78
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
79
blotting (data not shown). One ratiqnalization for this may be that because ATM and ATR both 
have relatively high molecular masses of -370 kDa (Chen and Lee, 1996), these proteins may not 
have been effectively transferred from the polyacrylamide gel used in SDS-PAGE onto the PVDF 
membrane during the semi-dry transfer. Indeed, the large size of ATM and ATR introduces some 
difficulties when performing immunoprecipitation assays, therefore scrupulous measures need to 
be undertaken to optimize experiments with these proteins in the future.
iv.) a-, (1-, y-tubulin, BRCA2, and Rb do not physically associate with Plk4
Numerous other proteins were tested as putative interacting partners with Plk4 on the 
basis of existing data showing direct or indirect association with other Plks. Feng and colleagues 
(1999) presented evidence that Plkl can physically associate with the tubulin proteins in a stable 
complex that persists during iiiterphase and mitosis. It was found that Plkl was able to 
phosphorylate the tubulins, which functions to adjust the stability and organization of microtubule 
structures that form the mitotic spindle (Feng et al, 1999). This is a particular significant event 
during mitosis since it ensures proper spindle assembly and thus accurate segregation of 
chromosomes to dividing cells. Spindle assembly initiates from the centrosomes, which are 
designated the ‘microtubule organizing centre’ (MTOC). y-tubulin is particularly ubiquitous at 
these structures, since it exists as part of a meshwork of proteins within the pericentriolar material 
of the centrosome; the spindle itself is composed of a- and p-tubulin protein as its monomeric 
subunits (Varmark, 2004). Plk4 has been confirmed to localize to centrosomes where it mediates 
its duplication during mitosis; overexpression of Plk4 can produce an excess of centrioles, while 
depletion of the protein through siRNA can cause progressive centriolar reduction (Bettancourt- 
Dias et al, 2005; Habedanck et al, 2005). The fact that Plk4 can localize to centrosomes makes 
the tubulin proteins reasonable candidates for interaction with Plk4. Co-immunoprecipitation 
assays, however, showed there was in fact no physical association between Plk4 and any of the 
tubulin proteins (data not shown). These results do not completely exclude the possibility of a
79
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putative association between Plk4 and a-, 0-, or y-tubulin. The centrosomes and mitotic spindle 
are structures that mature concomitantly with cell cycle progression. As the bipolar spindle
v
progressively lengthens, the need for a- and P-tubulins to polymerize the microtubules is greater, 
which should prompt an increase in their protein levels during M phase. Studies have confirmed a 
twofold increase in tubulin protein synthesis during mitosis in HeLa cells (Bravo and Celis, 
1980). If an interaction does exist between Plk4 and any of the tubulin proteins, and that 
association is highly transient, it may be necessary to enrich for cells in the mitotic phase through 
the addition o f nocodazole, for example; this would capture cells in a phase when maximal 
tubulin protein synthesis is occurring, and could increase the likelihood of capturing short-lived 
interactions between Plk4 and the tubulins.
BRCA2 is a tumor suppressor protein that functions by repairing double-stranded breaks 
in DNA, thus helping to maintain genomic stability and cell cycle progression (Lin et al, 2003). 
Evidence shows that Plkl is able to phosphorylate BRCA2 and that this association results in 
modulation of the tumor suppressor’s activity (Lin et al, 2003). A physical interaction between 
Plk4 and BRCA2 was not observed to occur based on the presented co-immunoprecipitation 
results (data not shown). In the study conducted by Lin and co-workers, however, cells were 
initially synchronized in G2/M phase prior to assessing for any putative interactions between Plkl 
and BRCA2; this represents the stage of maximal Plkl expression. Similarly, Plk4 exhibits the 
highest proteins levels at M phase (Hudson et al, 2001). It is possible that no physical association 
was observed between Plk4 and BRCA2 because the majority of cells were asynchronous, 
suggesting that expression of either gene may not be at its maximum potential. Cell 
synchronization through the addition of nocodazole, a microtubule-depolymerizing agent that 
induces G2/M block (Cooper, 2003), followed by release arrested cells, may enhance the 
potential for BRCA2 to associate with Plk4 if it is indeed a bona fide  interacting partner .
Retinoblastoma (Rb) is a classical tumor suppressor protein that suppresses the 
transcription of critical targets in a cell cycle-dependent manner and thus prevents abnormal
80
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cellular proliferation (Wiman et al, 1993). In early G l, Rb exists in an unphosphorylated state; 
however, the protein progressively attains a hyperphosphorylated condition in late Gl that
» - v '
persists until the end of M phase (Weinberg, 1995). One study showed how Plkl is a target of the 
Rb tumor suppressor pathway such that Rb activation leads to suppression of Plkl activity 
(Gunawardena et al, 2004). Conversely, loss of Rb deregulates Plkl repression. To determine if 
Plk4 shows an association with Rb, various constructs encoding Plk4 protein were transfected 
into mammalian cells and lysates were subjected to co-immunoprecipitation. No physical 
association was detected between Rb and Plk4. Although Plk4 was not found to interact directly 
with Rb, it does not rule out the possibility that Plk4 still participates in the Rb transduction 
pathway and that intermediary proteins may be involved linking the two proteins in an indirect 
manner. Plkl repression by Rb was discovered to require a chromatin remodeling complex called 
SWI/SNF, which was in fact responsible for the histone deacetylation of the Plkl promoter region 
that prevented Plkl transcription (Gunawardena et al, 2004). Without SWI/SNF present in cells, 
Rb was no longer able to mediate inhibition of Plkl activity. It is possible that Plk4 is indirectly 
related to Rb activity rather than through a direct physical association and that third-party proteins 
are required for a functional link between Rb and Plk4 to be witnessed (Table 3).
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Table 3: Potential Candidate Interacting Partners of Plk4
Candidate P artner Tested Interaction with 
Plk4 
observed? (+/-)
Region of Plk4 
not required for 
interaction
Chk2 + Polo box 
Cryptic polo box
ATM + Polo box
ATR + Polo box
a-tubulin - N/A
P-tubulin - N/A
y-tubulin - N/A
BRCA2 - N/A
Rb - N/A
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Establishment o f  stable cell line expressing Plk4 and kinase dead K41M mutant
Previous experiments involving transient transfection of Flag-Plk4 vectors into various 
cell lines such as HEK-293, U20S, and mouse fibroblast 3T3 cells displayed very poor and 
inconsistent transfection efficiencies, as revealed by immunoblotting analyses. Decreased cell 
viability due to contamination or overconfluency may have contributed to such low gene 
expression, which often posed difficulties in performing further experiments that required ample 
protein levels; establishing a HEK-293 cell line that consistently retained the Plk4 gene would 
help circumvent those problems. Creating a cell line that stably expresses a gene of interest 
provides numerous advantages over the more transient methods typically used in molecular 
biology studies. Habedanck et al (2005) were able to establish inducible osteosarcoma epithelial 
U20S cell lines that stably express both Flag-Plk4 and a kinase dead Flag-D154A mutant Plk4, 
which were then utilized to study the effects of Plk4 overexpression on centrosome duplication. 
Two separate human embryonic kidney 293 (HEK-293) cell lines containing either a tetracycline- 
inducible Flag-Plk4 or a kinase defective Flag-K41M vector were generated in this study. Full- 
length Flag-Plk4, as well as the kinase defective Flag-K41M mutant, were both cloned into an 
expression vector that was under control of a tetracycline repressor. By making the expression of 
Plk4 as part of an inducible system, potential toxicity to the cells due to prolonged Plk4 
expression could be avoided. For example, previous experiments have shown that exogenous 
Plk4 expression can induce the formation of multiple centrioles, which can cause aberrant mitotic 
spindle assembly and subsequently contribute to genomic instability (Habedanck et al, 2005). 
Without a means of temporally modulating the expression of Plk4 in the stable cell lines, it is 
possible that mitotic defects will amplify with each round of cell division, thus making the cells 
severely compromised for further experimentation. Therefore, by making the expression of Plk4 
under control of a tetracycline (Tet) repressor, one can manipulate when the protein is expressed 
and limit the exposure of the cell to potential adverse effects associated with overexpression.
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CHAPTER VII 
FUTURE DIRECTIONS 
The results described in this study provide preliminary evidence for Chk2, ATM, and 
ATR being interacting partners with Plk4. To extend the relevance of these findings, one 
important question that should be addressed is: does Plk4 phosphorylate these candidate partners 
or vice versa? Plk4, Chk2, ATM, and ATR are all protein kinases, which function by adding a 
phosphate to their respective substrates, generally leading to a change in the substrate’s 
regulation, activity, or stability. As previously mentioned, Plkl and Plk3 both physically interact 
with Chk2, leading to its phosphorylation (Tsetkov et al, 2003; Bahassi et al, 2006). In vitro 
kinase assays examining Chk2 as a substrate of Plk4 would supplement the observed physical 
association with a functional relevance. Similar investigations on potential kinase:substrate 
relations between Plk4 and ATM/ATR can also be conducted. Conversely, the possibility remains 
that Chk2, ATM, and ATR may in fact phosphorylate Plk4, leading to potential changes in its 
regulation within the cell. Tec, a protein tyrosine kinase (PTK) critically involved in mediating 
cytokine and antigen receptor signaling, currently remains the only enzyme known to 
phosphorylate Plk4 (Yamashita et al, 2001). Yeast two-hybrid analysis and immunoprecipitation 
detected Plk4 as an interacting partner of Tec kinase, while in vitro kinase assay confirmed Tec 
can phosphorylate and induce activity of Plk4 (Yamashita et al, 2001). Therefore, it seems that in 
vitro kinase assays are a logical next step to the presented findings. The experiments conducted in 
this study reveal that Plk4 can interact with each of these proteins independently of one another. 
Chk2, ATM, and ATR, however, are well-characterized participants in the DNA-damage 
response pathway with clearly defined functional associations. ATM and ATR are both 
responsible for phosphorylating Chk2 at Thr-68, a modification that transforms Chk2 into its 
active form (Matsuoka et al, 2000). Whereas Chk2 is phosphorylated by ATM upon IR exposure, 
ATR interacts and phosphorylates Chk2 when prompted by UV damage (Tsetkov et al, 2003).
84
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Despite the findings o f this study, the possibility remains that the association of Plk4 with these 
checkpoint kinases cannot simply be defined as a direct, linear interaction, but rather as a 
component of a larger complex of proteins consisting of bridging associations. To investigate this 
possibility, interactions between Plk4 and a particular candidate partner should be analyzed in the 
absence of the other proteins to determine if the physical association is retained. For example, 
ATM-deficient cell lines can be employed as an overexpression system for Plk4 followed by pull­
down assays of the whole cell lysates with Chk2 antibody; if Plk4 and Chk2 are still able to co- 
immunoprecipitate in cells lacking ATM, this would corroborate the findings that these two 
kinases have a physical interaction. Analyzing the effects of ATM- and ATR-inhibiting agents 
such as caffeine (ATM and ATR) and Wortmannin (ATM) on the associative status between Plk4 
and Chk2 would offer similar evidence. Furthermore, co-expression of differentially-tagged 
constructs for Plk4 and Chk2 (of ATR or ATM) in HEK-293 cells and subsequent in vitro co- 
immunoprecipitation and immunoblotting analyses would reveal if the observed physical 
interactions persist independently. In addition, the effects of radiomimetic agents such as 
adriamycin on Plk4 kinase activity should be explored. This would lend itself to investigating 
how genotoxic stress would affect Plk4’s physical and potentially functional association with 
ATM, ATR, and Chk2, should these proteins be revealed to be putative substrates. Reciprocal co- 
immunoprecipitations would also significantly bolster the findings of a physical interaction with 
Plk4 and the candidate partners. Efforts to reciprocally immunoprecipitate Chk2 with Plk4 were 
futile. In addition, attempts to pull down Plk4 and detect a co-immunoprecipitation with ATM or 
ATR were also unsuccessful, likely due to the large size (370 kDa) of these kinases. It would be 
worthwhile to rigorously optimize this experiment so as to provide further validity to the physical 
interaction that was originally observed. Although no physical interaction was detected with Plk4 
and BRCA2, Rb, a-, P-, or y-tubulin in this study, sub-optimal conditions may have precluded the 
detection of possibly low-affinity or transient interactions. As described previously, the 
enrichment of cells arrested at the G2/M phase through nocodazole addition may greatly enhance
85
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the likelihood of revealing a physical association, since Plk4 is expressed at maximal levels 
during this phase.
Finally, the creation of the Plk4 stable cell lines as achieved in this study will be an 
invaluable tool in pursuing the aforementioned experiments. The enhanced and consistent gene 
expression afforded by these cell lines facilitate further studies that require the presence of a 
tagged Plk4 protein such as in protein interaction assays, as well as localization experiments, 
kinase assays, cell cycle analyses, and DNA damage experiments.
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APPENDICES 
APPENDIX A
Customized primers used for sequencing of PCDN4/TO Flag Plk4
Primer
name
Sequence Tm
ET281 5’ GAT AAG AAA GCC ATG TAC AAA GCA GGA ATG G 3’ 60 °C
ET282 5’ CAG GTC TTT CAA AAG ATC CAG AAC TAC TGG 3’ 60 °C
ET283 5 ’ TGT CGT AAT AAC CCC GCC CCG 3 ’ 58°C
ET284 5 ’ CGC ATC TTC AAT CAC TCT CCC CCG 3 ’ 61 °C
* Primers were designed using Primer3, a web-based program used to facilitate the creation 
of oligonucleotide sequences utilized specifically for the sequencing of desired regions within 
DNA (Rozen and Skaletsky, 2000).
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APPENDIX B
Antibodies against putative interacting partners used in co-immunoprecipitation assays
Antibody Polyclonal or 
Monoclonal
Origin Company
Anti-ATM Monoclonal Mouse Sigma
Anti-ATR Polyclonal Mouse Calbiochem
Anti-Chk2 Monoclonal Mouse Sigma
Anti-a-tubulin Monoclonal Mouse Sigma
Anti-p-tubulin Monoclonal Mouse Sigma
Anti-y-tubulin Monoclonal Mouse Sigma
Anti-BRCA2 Polyclonal Rabbit Sigma
Anti-Rb Monoclonal Rabbit Sigma
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